{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Notes Report\n",
    "This report will answer:\n",
    "1. What do the notes contain? -- How do they differ structurally? Semantically? \n",
    "2. Statistical info about the note category. Token count? Note count per icustay?\n",
    "3. Statistical comparison between categories"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "rad_path = f'/data/datasets/mimiciv_notes/physionet.org/files/mimic-iv-note/2.2/note/radiology.csv'\n",
    "dis_path = f'/data/datasets/mimiciv_notes/physionet.org/files/mimic-iv-note/2.2/note/discharge.csv'\n",
    "rad_cohort_path = f'/home/ugrads/a/aa_ron_su/BoXHED_Fuse/JSS_SUBMISSION_NEW/data/till_end_mimic_iv_extra_features_train_NOTE_TARGET1_FT_rad.csv'\n",
    "dis_cohort_path = f'/home/ugrads/a/aa_ron_su/BoXHED_Fuse/JSS_SUBMISSION_NEW/data/till_end_mimic_iv_extra_features_train_NOTE_TARGET1_FT.csv'\n",
    "rad_c_df = pd.read_csv(rad_cohort_path)\n",
    "dis_c_df = pd.read_csv(dis_cohort_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\u001b[0m\u001b[01;34mfinal\u001b[0m/\n",
      "\u001b[01;34mfinal2\u001b[0m/\n",
      "\u001b[01;34mfinal3\u001b[0m/\n",
      "\u001b[01;34mfinal3_test\u001b[0m/\n",
      "\u001b[01;34mfinal_rad1_test\u001b[0m/\n",
      "mimic_iv_test.csv\n",
      "mimic_iv_test_NOTE.csv\n",
      "mimic_iv_test_NOTE_TARGET1.csv\n",
      "mimic_iv_train.csv\n",
      "mimic_iv_train_NOTE.csv\n",
      "mimic_iv_train_NOTE_TARGET1.csv\n",
      "testing.csv\n",
      "till_end_mimic_iv_extra_features_test.csv\n",
      "till_end_mimic_iv_extra_features_test_NOTE.csv\n",
      "till_end_mimic_iv_extra_features_test_NOTE_rad.csv\n",
      "till_end_mimic_iv_extra_features_test_NOTE_TARGET1.csv\n",
      "till_end_mimic_iv_extra_features_test_NOTE_TARGET1_FT.csv\n",
      "till_end_mimic_iv_extra_features_test_NOTE_TARGET1_FT_rad.csv\n",
      "till_end_mimic_iv_extra_features_test_NOTE_TARGET3_FT_rad.csv\n",
      "till_end_mimic_iv_extra_features_test_NOTE_TARGET5_FT_rad.csv\n",
      "till_end_mimic_iv_extra_features_train.csv\n",
      "till_end_mimic_iv_extra_features_train_NOTE.csv\n",
      "till_end_mimic_iv_extra_features_train_NOTE_rad.csv\n",
      "till_end_mimic_iv_extra_features_train_NOTE_TARGET1.csv\n",
      "till_end_mimic_iv_extra_features_train_NOTE_TARGET1_FT.csv\n",
      "till_end_mimic_iv_extra_features_train_NOTE_TARGET1_FT_rad.csv\n",
      "till_end_mimic_iv_extra_features_train_NOTE_TARGET3_FT_rad.csv\n",
      "till_end_mimic_iv_extra_features_train_NOTE_TARGET5_FT_rad.csv\n",
      "training.csv\n"
     ]
    }
   ],
   "source": [
    "%ls /home/ugrads/a/aa_ron_su/BoXHED_Fuse/JSS_SUBMISSION_NEW/data/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "rad_cohort_path_og = f'/home/ugrads/a/aa_ron_su/BoXHED_Fuse/JSS_SUBMISSION_NEW/data/till_end_mimic_iv_extra_features_train_NOTE_rad.csv'\n",
    "og_rad_c_df = pd.read_csv(rad_cohort_path_og)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "76158"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "og_rad_c_df.NOTE_ID.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "76148"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "rad_c_df.NOTE_ID.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([nan, '10667727-RR-21', '14124344-RR-77', '17856327-RR-23',\n",
       "       '16497039-RR-39', '12710598-RR-17', '12557579-RR-17',\n",
       "       '10393331-RR-21', '12954060-RR-14', '11196689-RR-19',\n",
       "       '10956880-RR-9'], dtype=object)"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "notes = og_rad_c_df[~ og_rad_c_df.NOTE_ID.isin(rad_c_df.NOTE_ID)].NOTE_ID.unique()\n",
    "notes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>SUBJECT_ID</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NOTE_ID</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>10393331-RR-21</th>\n",
       "      <td>9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10667727-RR-21</th>\n",
       "      <td>67</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10956880-RR-9</th>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11196689-RR-19</th>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12557579-RR-17</th>\n",
       "      <td>32</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12710598-RR-17</th>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12954060-RR-14</th>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14124344-RR-77</th>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16497039-RR-39</th>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17856327-RR-23</th>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                SUBJECT_ID\n",
       "NOTE_ID                   \n",
       "10393331-RR-21           9\n",
       "10667727-RR-21          67\n",
       "10956880-RR-9            6\n",
       "11196689-RR-19           5\n",
       "12557579-RR-17          32\n",
       "12710598-RR-17          12\n",
       "12954060-RR-14          15\n",
       "14124344-RR-77          39\n",
       "16497039-RR-39          17\n",
       "17856327-RR-23           2"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "subj_note_view = og_rad_c_df[~og_rad_c_df.NOTE_ID.isin(rad_c_df.NOTE_ID)][['NOTE_ID', 'SUBJECT_ID']].groupby('NOTE_ID').count()\n",
    "subj_note_view"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4329"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "og_rad_c_df[~og_rad_c_df.NOTE_ID.isin(rad_c_df.NOTE_ID)].SUBJECT_ID.nunique()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. What do the notes contain?"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The discharge table contains discharge summaries for hospitalizations. Discharge summaries are long form narratives which describe the reason for a patientâ€™s admission to the hospital, their hospital course, and any relevant discharge instructions. \n",
    "\n",
    "The radiology table contains free-text radiology reports associated with radiography imaging. Radiology reports cover a variety of imaging modalities: x-ray, computed tomography, magnetic resonance imaging, ultrasound, and so on. Free-text radiology reports are semi-structured and usually follow a consistent template for a given imaging protocol"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\nEXAMINATION\\nINDICATION\\nDOSE\\nCOMPARISON\\nFINDINGS\\nHead_CTA\\nIMPRESSION\\n'"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import numpy as np\n",
    "\n",
    "np.random.seed(1)\n",
    "n = rad_c_df.shape[0]\n",
    "idxs = [np.random.randint(n) for _ in range(3)]\n",
    "\n",
    "# print(rad_c_df.iloc[idxs[0]].text)\n",
    "# print( '-' * 40)\n",
    "'''\n",
    "HISTORY\n",
    "FINDINGS\n",
    "'''\n",
    "\n",
    "# print(rad_c_df.iloc[idxs[1]].text)\n",
    "# print( '-' * 40)\n",
    "'''\n",
    "INDICATION\n",
    "COMPARISON\n",
    "TECHNIQUE\n",
    "FINDINGS\n",
    "IMPRESSION\n",
    "'''\n",
    "\n",
    "# print(rad_c_df.iloc[idxs[2]].text)\n",
    "# print( '-' * 40)\n",
    "'''\n",
    "EXAMINATION\n",
    "INDICATION\n",
    "DOSE\n",
    "COMPARISON\n",
    "FINDINGS\n",
    "Head_CTA\n",
    "IMPRESSION\n",
    "'''"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Radiology is structured with headings in all caps. These vary in type, but generally there is some form of imaging performed followed by findings, impression, comparison, etc."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'\\n----------------------------------------\\n----------------------------------------\\n \\npersonal info...\\nChief Complaint:\\nMajor Surgical or Invasive Procedure:\\nHistory of Present Illness:\\nPast Medical History:\\nSocial History:\\nFamily History:\\nPhysical Exam:\\n\\nCT ABDOMEN W/O CONTRAST Study Date of ___ 1:14 ___ \\nCT HEAD W/O CONTRAST Study Date of ___ 10:___vidence of acute intracranial process.  Chronic changes \\nCT ABD & PELVIS W/O CONTRAST Study Date of ___ 4:09 ___ \\nCT CHEST W/O CONTRAST Study Date of ___ 4:23 ___ \\nCT ABD & PELVIS W/O CONTRAST Study Date of ___ 10:56 ___ \\n\\nBrief Hospital Course:\\nMedications on Admission:\\nDischarge Medications:\\nDischarge Disposition:\\nFacility:\\nDischarge Diagnosis:\\nDischarge Condition:\\nDischarge Instructions:\\nFollowup Instructions:\\n'"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import numpy as np\n",
    "\n",
    "np.random.seed(1)\n",
    "n = dis_c_df.shape[0]\n",
    "idxs = [np.random.randint(n) for _ in range(3)]\n",
    "\n",
    "# print(dis_c_df.iloc[idxs[0]].text)\n",
    "# print( '-' * 40)\n",
    "'''\n",
    "personal info... (hidden data for privacy)\n",
    "  Service: Neurosurgery\n",
    "  Chief Complaint: Fall\n",
    "  Major Surgical or Invasive Procedure: None\n",
    "  Name:  ___.           Unit No:   ___\n",
    "  Admission Date:  ___              Discharge Date:   ___\n",
    "  Date of Birth:  ___             Sex:   M\n",
    "  ...\n",
    "Service: NEUROSURGERY\n",
    "Chief Complaint:\n",
    "Major Surgical or Invasive Procedure:\n",
    "History of Present Illness:\n",
    "Past Medical History:\n",
    "Social History:\n",
    "Family History:\n",
    "Physical Exam: \n",
    "\n",
    "On Discharge: \n",
    "Pertinent Results:\n",
    "CT Head:\n",
    "IMPRESSION: \n",
    "\n",
    "Brief Hospital Course:\n",
    "Medications on Admission:\n",
    "Discharge Medications: \n",
    "Discharge Disposition: \n",
    "Discharge Diagnosis:\n",
    "Discharge Condition:\n",
    "Discharge Instructions: \n",
    "Followup Instructions:\n",
    "'''\n",
    "\n",
    "# print(dis_c_df.iloc[idxs[1]].text)\n",
    "# print( '-' * 40)\n",
    "'''\n",
    "personal info...\n",
    "Chief Complaint:\n",
    "Major Surgical or Invasive Procedure:\n",
    "History of Present Illness:\n",
    "Review of sytems:  \n",
    "Past Medical History:\n",
    "Social History:\n",
    "Family History:\n",
    "Physical Exam: \n",
    "\n",
    "GU: no foley  \n",
    "Ext: \n",
    "Neuro: \n",
    "Pertinent Results:\n",
    "Alpha-1 antitrypsin level: 31\n",
    "Alpha-1 antitrypsin phenotype:\n",
    "MICROBIOLOGY:\n",
    "IMAGING:\n",
    "\n",
    "Brief Hospital Course:\n",
    "#. Ascitic fluid leakage: \n",
    "#. Cirrhosis: \n",
    "#. Pneumonia: \n",
    "Medications on Admission:\n",
    "Discharge Medications:\n",
    "Discharge Disposition:\n",
    "Discharge Diagnosis:\n",
    "Discharge Condition:\n",
    "Discharge Instructions:\n",
    "Followup Instructions:\n",
    "'''\n",
    "\n",
    "# print(dis_c_df.iloc[idxs[2]].text)\n",
    "# print( '-' * 40)\n",
    "'''\n",
    "----------------------------------------\n",
    "----------------------------------------\n",
    " \n",
    "personal info...\n",
    "Chief Complaint:\n",
    "Major Surgical or Invasive Procedure:\n",
    "History of Present Illness:\n",
    "Past Medical History:\n",
    "Social History:\n",
    "Family History:\n",
    "Physical Exam:\n",
    "\n",
    "CT ABDOMEN W/O CONTRAST Study Date of ___ 1:14 ___ \n",
    "CT HEAD W/O CONTRAST Study Date of ___ 10:___vidence of acute intracranial process.  Chronic changes \n",
    "CT ABD & PELVIS W/O CONTRAST Study Date of ___ 4:09 ___ \n",
    "CT CHEST W/O CONTRAST Study Date of ___ 4:23 ___ \n",
    "CT ABD & PELVIS W/O CONTRAST Study Date of ___ 10:56 ___ \n",
    "\n",
    "Brief Hospital Course:\n",
    "Medications on Admission:\n",
    "Discharge Medications:\n",
    "Discharge Disposition:\n",
    "Facility:\n",
    "Discharge Diagnosis:\n",
    "Discharge Condition:\n",
    "Discharge Instructions:\n",
    "Followup Instructions:\n",
    "'''"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Statistical info about the note category. \n",
    "Token count? Note count per icustay?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "import os\n",
    "sys.path.append(\"/home/ugrads/a/aa_ron_su\")\n",
    "# from BoXHED_Fuse.src.helpers import tokenization\n",
    "\n",
    "from transformers import AutoTokenizer\n",
    "tokenizer = AutoTokenizer.from_pretrained('../models/Clinical-T5-Base/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "def tokenization(tokenizer, batched_text):\n",
    "    return tokenizer(batched_text['text'], padding = False, truncation=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "1b7ec9a584164fd4a817337ab7143ba7",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/76148 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Token indices sequence length is longer than the specified maximum sequence length for this model (608 > 512). Running this sequence through the model will result in indexing errors\n"
     ]
    },
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "4cd7aa400b38496dac172eab0ae243e4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Map:   0%|          | 0/14573 [00:00<?, ? examples/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from functools import partial\n",
    "from datasets import Dataset\n",
    "rad_c_ds = Dataset.from_pandas(rad_c_df).select_columns(['text'])\n",
    "tokens_rad = rad_c_ds.map(partial(tokenization, tokenizer), batched = True, batch_size = len(rad_c_ds) // 10)\n",
    "\n",
    "dis_c_ds = Dataset.from_pandas(dis_c_df).select_columns(['text'])\n",
    "tokens_dis = dis_c_ds.map(partial(tokenization, tokenizer), batched = True, batch_size = len(dis_c_ds) // 10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "note_token_lens_rad = [len(t['input_ids']) for t in tokens_rad]\n",
    "note_token_lens_dis = [len(t['input_ids']) for t in tokens_dis]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "MEAN: 265.7898828596943\n",
      "MEDIAN: 179.0,\n",
      "MAX: 3298\n",
      "MIN: 5\n",
      "MEAN: 3368.4673025458037\n",
      "MEDIAN: 3191.0,\n",
      "MAX: 16248\n",
      "MIN: 256\n"
     ]
    }
   ],
   "source": [
    "def summary_stats(data):\n",
    "    print(f'MEAN: {np.mean(data)}\\nMEDIAN: {np.median(data)},\\nMAX: {np.max(data)}\\nMIN: {np.min(data)}')\n",
    "\n",
    "summary_stats(note_token_lens_rad)\n",
    "summary_stats(note_token_lens_dis)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Radiology reports are more succinct. With an average token length of 265, their information easily fits into a 512 token transformer input.\n",
    "On the other hand, discharge notes are much longer at > 3000 tokens on average and will need to be truncated."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "agree with reading.\n",
      "\n",
      "\n",
      " \n",
      "Name:  ___                   Unit No:   ___\n",
      " \n",
      "Admission Date:  ___              Discharge Date:   ___\n",
      " \n",
      "Date of Birth:  ___             Sex:   F\n",
      " \n",
      "Service: SURGERY\n",
      " \n",
      "Allergies: \n",
      "No Drug Allergy Information on File\n",
      " \n",
      "Attending: ___.\n",
      " \n",
      "Chief Complaint:\n",
      "s/p fall\n",
      " \n",
      "Major Surgical or Invasive Procedure:\n",
      "None\n",
      "\n",
      " \n",
      "Brief Hospital Course:\n",
      "Ms. ___ is a ___ who sustained a fall at home.  She was \n",
      "found to have a large acute on chronic subdural hematoma with \n",
      "extensive midline shift and herniation.  Her clinical exam \n",
      "revealed no brain stem reflexes.  She was evaulated by \n",
      "neurosurgery who deemed the injury to severe to perform emergent \n",
      "surgical decompression.  A family meeting was had and they \n",
      "elected to make her CMO.  She was extubated and expired shortly \n",
      "thereafter. \n",
      " \n",
      "Discharge Disposition:\n",
      "Expired\n",
      " \n",
      "Discharge Diagnosis:\n",
      "Traumatic acute on chronic subdural hematoma\n",
      "Respiratory Failure\n",
      "\n",
      " \n",
      "Discharge Condition:\n",
      "Expired\n",
      "\n",
      " \n",
      "Followup Instructions:\n",
      "___\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(tokens_rad[int(np.argmin(note_token_lens_rad))]['text'])\n",
    "print(tokens_dis[int(np.argmin(note_token_lens_dis))]['text'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ANGIOGRAPHY AND INTERVENTIONAL REPORT\n",
      "\n",
      "CLINICAL HISTORY:  Patient is a ___ lady with a history of\n",
      "intervascular coiling of her paraclinoid cavernous dysplastic right IC\n",
      "aneurysm ___ years ago and her recent diagnostic cerebral angiography confirmed\n",
      "a recanalization on this aneurysm and dysplastic segment at its cavernous\n",
      "segment.  She is here for a diagnostic cerebral angiography and fixing her\n",
      "right ICA dysplastic aneurysm using a flow diverting stent (pipeline stent).\n",
      "\n",
      "FIRST OPERATIVE SURGEON:  Dr. ___.\n",
      "\n",
      "FIRST ASSISTANT:  Dr. ___.\n",
      "\n",
      "SECOND ASSISTANT:  Dr. ___.\n",
      "\n",
      "OTHER ASSISTANTS:  Dr. ___ and ___ \n",
      "\n",
      "PROCEDURE PERFORMED:  Diagnostic cerebral angiogram by catheterization\n",
      "injection into the right innominate artery, right common carotid artery, right\n",
      "internal carotid artery, spin angiogram by injecting into the right internal\n",
      "carotid artery and post processing of the data under supervision of concurrent\n",
      "attending physician in ___ separate workstation and making a 3D construction and\n",
      "applying the data for further interpretation, dictation and management\n",
      "purposes, right internal carotid artery flow diversion pipeline stenting,\n",
      "right common femoral artery roadmap angiogram, closure of the right common\n",
      "femoral artery puncture site using Angio-Seal vascular closure device.\n",
      "\n",
      "ANESTHESIA:  General.\n",
      "\n",
      "DESCRIPTION OF PROCEDURE:  An informed consent was signed by the patient.  The\n",
      "patient was transferred to the angiography unit and was transferred to the\n",
      "radiology table.  Subsequently, under general anesthesia a septic precautious\n",
      "prepping and draping of bilateral groin in a sterile fashion, access to the\n",
      "right common femoral artery was obtained using a modified Seldinger technique\n",
      "and micropuncture set.  Subsequently an 8 ___, 25 cm Terumo long sheath was\n",
      "inserted into the right common femoral artery.  Using a 5 ___ Berenstein 2\n",
      "catheter over a 0.038-inch Terumo wire we tried connect it to continuous\n",
      "heparinized saline and power injector via a rotating valve, we tried to get\n",
      "access into the right common carotid artery.  Multiple try using a catheter\n",
      "failed.  We changed this catheter into a Berenstein 1 and we tried multiple\n",
      "times again and it failed.  Subsequently we tried the 5 ___ VTK\n",
      "030H/__9:10___ catheter over a 0.035-inch Terumo wire and we tried multiple\n",
      "times; however, access into the right common carotid artery as a result of\n",
      "type 3 aortic arch and very unstable position of the catheter was not possible\n",
      "and all attempts using this catheter and wire are failed.  Again we changed\n",
      "the catheter into ___ 2 soft catheter and we tried to get access into the\n",
      "right common carotid artery.  Forming this catheter was possible in aortic\n",
      "arch using a Seldinger technique; however, access into the right common\n",
      "carotid artery using a pretty soft and unstable catheter was technically\n",
      "difficult and made advancing the glidewire very difficult.  Therefore we\n",
      "changed this ___ 2 soft to ___ 2 regular catheter and we tried to form this\n",
      "catheter via left subclavian, left common carotid or finally into the aortic\n",
      "arch all attempt failed to form this catheter.  Therefore finally we tried\n",
      "multiple times to form this catheter by advancing a wire and under roadmap\n",
      "guidance into the left common iliac artery and finally this forming was\n",
      "successfully performed and catheter regular ___ 2 was formed by advancing this\n",
      "catheter into the left common iliac.  After forming this regular ___ 2\n",
      "catheter it was advanced into the aortic arch and at this time we were able to\n",
      "get access into the right innominate and subsequently right common carotid\n",
      "artery proximal portion.  At this time because of still unstable position of\n",
      "this catheter and the difficult angle from the aortic arch into the innominate\n",
      "and then common carotid artery it was impossible to advance catheter into more\n",
      "distal common carotid artery in the right side and finally into the right\n",
      "internal carotid artery.  Therefore we tried multiple wires and finally we\n",
      "advanced two 018 exchange length V-18 control wire into the internal carotid\n",
      "artery cervical portion and we tried to exchange this with a 5 ___ glide\n",
      "catheter to be able for subsequent exchanger, however multiple tries again\n",
      "failed and we had to redo the entire game again and reshape into catheter in\n",
      "the left common iliac artery and advance it and get access into the proximal\n",
      "right common carotid artery.\n",
      "\n",
      "Finally, after parking the tip into regular ___ 2 catheter at the proximal\n",
      "right common carotid artery under roadmap guidance, we advanced two V-18\n",
      "control wire and parked the tip of this wires at the distal cervical right ICA\n",
      "after its first loop and then exchanged with regular ___ 2 catheter with a 6\n",
      "___ 90 cm Shuttle sheath.  This exchange was successful with the form and\n",
      "just we parked the tip of this Shuttle sheath at the proximal cervical right\n",
      "ICA before its first loop.  At this time we advanced a 5 ___ ___ 058\n",
      "125-cm intracranial support over an assembly including Marksman catheter 160\n",
      "cm over a Synchro-2 at the standard microwire.  After advancement this\n",
      "assembly was found at the transition between the ___ and Marksman catheter\n",
      "is unstable and we were not able to advance and pass the ___ catheter\n",
      "beyond the first loop and it was difficult to pass that severely angled first\n",
      "ICA cervical curve.  At this time even we temporarily change this Marksman\n",
      "catheter into a Rapid Transit catheter and we tried to push the ___\n",
      "catheter up and pass the second carotid cervical loop, however it is again\n",
      "same.  At this point we decided to have the ___ tip at that position and\n",
      "instead advance the Marksman catheter over a Synchro-2 wire and this assembly\n",
      "go inside the ___ 03___ 136 distal access catheter 3.9 ___ and this new\n",
      "assembly (___ over Marksman and over a Synchro-2 standard wire) was advanced\n",
      "together and successfully passed the thickened right ICA cervical loop beyond\n",
      "the ___ and at this time we pass the ___ catheter at the loop of cervical\n",
      "right ICA just before the right ICA stenosis area through petrous segment and\n",
      "then we advanced the Marksman catheter over a Synchro-2 microwire and\n",
      "successfully passed a tortuous right ICA cavernous and supraclinoid anatomy\n",
      "all the way into the distal right M1.  At this time the wire was retrieved and\n",
      "we advanced the first pipeline stenting which was a 4.50 mm x 25 mm pipeline\n",
      "embolization device.  Using standard technique this pipeline device was\n",
      "deployed from the supraclinoid segment all the way down to the proximal neck\n",
      "of this dysplastic cavernous segment aneurysm successfully and without any\n",
      "difficulty.  At this time as the dysplastic segment of the right ICA was\n",
      "really a long segment, and we had not covered all dysplastic segment therefore\n",
      "we decided to deploy a second stent telescoping the first stent down to cover\n",
      "the dysplastic segment.  Therefore we advanced a 4.75 mm x 25 mm pipeline\n",
      "embolization device and we tried to deploy from the middle of the previous\n",
      "pipeline all the way down.  However, when we were pulling down the catheter\n",
      "and stent together it jumped down because of severe tension inside the system\n",
      "as a result of significant tortuosity the course of this artery and we were\n",
      "not able to completely fluoroscoping the second stent inside the first stent. \n",
      "However we were able to deploy this stent just from the proximal portion of\n",
      "the previous stent all the way down to the proximal dysplastic right ICA\n",
      "segment.  Intermittent check angiography was performed after this line the\n",
      "second stent only the inferior third of the dysplastic segment was uncovered\n",
      "by flow diverting stents.  Therefore we pulled down the wire and decided to\n",
      "deploy the third stent fluoroscoping the second stent all the way to cover the\n",
      "entire dysplastic segment.  At this point we lost the wire access.  Therefore\n",
      "we advanced the Marksman catheter over a Synchro-2 wire and we finally\n",
      "successfully able to get access into the lumen of the second stent and the\n",
      "pipeline stent was advanced the Marksman catheter into the distal part of the\n",
      "second stent and then we advanced the third pipeline stent which was a 4.75 mm\n",
      "x 30 mm pipeline embolization device.  This stent was also successfully\n",
      "deployed over the fluoroscopy guidance from the middle of the second stent all\n",
      "the way down covering the entire lower third of the dysplastic segment up to\n",
      "the petrous segment.  At this time we have successfully covered the entire\n",
      "dysplastic right petrous cavernous segment of the right ICA and the dysplastic\n",
      "aneurysmal neck.  After deploying this stent the check angiogram showed\n",
      "narrowing at the proximal possibly dysplastic segment and with sluggish\n",
      "overflow.  At this moment we decided to do a balloon angioplasty of this\n",
      "proximal segment.  Therefore the Marksman catheter and wire were removed.  We\n",
      "tried to advance a 3.5 mm x 20 mm Sprinter Legend RX (coronary balloon)\n",
      "through the DAC catheter, however it was difficult to advance this balloon\n",
      "into the DAC.  Therefore we removed the DAC catheter and then we advance the\n",
      "balloon over the Synchro-2 wire and directly through the ___ catheter and\n",
      "try to center the balloon.  However at the last moment when we pushed balloon\n",
      "catheter the entire system including the Shuttle sheath lost its position and\n",
      "fell down into the aortic arch and we were not able to proceed.  Before\n",
      "advancing the balloon catheter we had perform the check angiogram and this\n",
      "angiogram showed significant opening of the this stenotic area and normal\n",
      "overflow via the lumen of this flow newly deployed flow diverting stent and\n",
      "patency of supraclinoid ICA and its PCOM and anterior choroidal branches and\n",
      "finally ACA and MCA branches without any thromboembolic complications. \n",
      "Therefore as we had this satisfactory angiography we decided to suspect the\n",
      "angiography and very difficult and risky access into the right common carotid\n",
      "artery, we decided not to proceed with the balloon angioplasty.\n",
      "\n",
      "Finally the right common femoral artery sheath was pulled down and right\n",
      "common iliac artery a roadmap angiography was performed and we confirmed the\n",
      "patency of the artery, its caliber and ruled out any vascular dissection or\n",
      "stenosis or vasospasm and also we confirmed that the puncture site is beyond\n",
      "the bifurcation and artery was suitable for Angio-Seal device, therefore we\n",
      "removed this sheath and using the standard technique we closed the vascular\n",
      "puncture site using this 8 ___ Angio-Seal vascular closure device.  This\n",
      "procedure was accomplished without complication and the patient remained\n",
      "neurologically intact afterwards.  No procedure related complication was\n",
      "noted.\n",
      "\n",
      "Of note, ___ unit of heparin was injected at the beginning of the procedure\n",
      "and baseline ACT was checked which showed 160.  Subsequently after advancing\n",
      "for Shuttle sheath another 5000 unit of heparin was injected and instantly ACT\n",
      "was checked and also instantly ___ unit of heparin was checked and ACT was\n",
      "kept between 250 and 300.  Finally we injected about 10,000 unit of heparin.\n",
      "\n",
      "IMAGE FINDINGS:\n",
      "1.  The aortic arch is a type 3 and very difficult and unstable arch with\n",
      "acute angle into the right innominate and common carotid artery and most\n",
      "difficult access vascular anatomy.\n",
      "2.  Right common carotid artery injection showed a good overflow and\n",
      "opacification distally within the right internal carotid artery demonstrates\n",
      "an extremely tortuous right cervical carotid artery.  There is an obvious\n",
      "enlarged fusiform dilatation and aneurysm of the right ICA from the petrous\n",
      "cavernous segment about 2 cm.  There is previous coiling seen at the top of\n",
      "the aneurysm with no obvious recanalization in the area of the aneurysm but it\n",
      "is unclear if there is any thrombus found in this.  The rest of the ICA\n",
      "including ophthalmic and PCOM, anterior choroidal artery are seen and\n",
      "opacified very well with normal catheterization of the ACA and MCA. \n",
      " 3.  Right common iliac artery injection showed very well overflowing into the\n",
      "right common femoral artery and superficial femoral artery and external iliac\n",
      "artery without any evidence of vasospasm or dissection.\n",
      "\n",
      "IMPRESSION:  This cerebral angiography confirmed the presence of tortuous\n",
      "cervical right ICA anatomy and a previously coiled right petrous cavernous\n",
      "segment ICA dysplastic aneurysm and a dysplastic segment involving at least 2\n",
      "cm of the right ICA at its petrous cavernous segment.  There was previous\n",
      "coiling from thrombus associated with decreased flow.  However, there was\n",
      "obvious recanalization at the base of this aneurysm along with the wide\n",
      "dysplastic petrous cavernous segment.  Three pipeline flow diverting stenting\n",
      "were successfully deployed from distal supraclinoid ICA all the way down\n",
      "proximal to the most proximal dysplastic right ICA segment.  These three\n",
      "pipeline stents successfully covered the neck of the aneurysm and all length\n",
      "of this dysplastic segment.  Final angiography showed early tunneling through\n",
      "diverting stents and association with the filling along the sidewalls without\n",
      "any proximal or distal thromboembolic complications.  Final angiographic\n",
      "outcome will be assessed with another angiography in six months.\n",
      "\n",
      "The patient remained neurologically stable afterwards.\n",
      "\n",
      "This procedure was performed by Dr. ___, and with assistance of\n",
      "Dr. ___ and ___ in order of\n",
      "their contribution.\n",
      "\n",
      " \n",
      "Name:  ___              Unit No:   ___\n",
      " \n",
      "Admission Date:  ___              Discharge Date:   ___\n",
      " \n",
      "Date of Birth:  ___             Sex:   M\n",
      " \n",
      "Service: MEDICINE\n",
      " \n",
      "Allergies: \n",
      "Dilantin / Sulfa (Sulfonamide Antibiotics) / morphine / abacavir\n",
      " \n",
      "Attending: ___.\n",
      " \n",
      "Chief Complaint:\n",
      "Dyspnea, altered sensorium\n",
      " \n",
      "Major Surgical or Invasive Procedure:\n",
      "___: endotracheal intubation\n",
      "___: brain biopsy \n",
      "___: re-intubation after extubation on ___: tracheostomy\n",
      "___: PEG placed\n",
      "\n",
      "___: endotracheal intubation\n",
      "___: brain biopsy \n",
      "___: re-intubation after extubation on ___: tracheostomy\n",
      "___: PEG placed\n",
      "\n",
      " \n",
      "History of Present Illness:\n",
      "This is a ___ year-old Male with PMH signficant for HIV/AIDS \n",
      "infection (last CD4 count of 24 and HIV VL of greater than 1 \n",
      "million ___ ___, currently on ARV regimen with very poor \n",
      "compliance), oxygen-dependent COPD (on 4L NC at home), chronic \n",
      "diarrhea, ___ tobacco use, history of seizures ___ the setting \n",
      "of Toxoplasmosis, ___ hypokalemia presenting with worsening \n",
      "SOB with evidence of acute encephalopathy and evidence of \n",
      "presumably new left-sided brain mass intubated for airway \n",
      "protection.\n",
      "\n",
      "Patient was recently discharged from ___ ___ to \n",
      "___ with an episode of shortness of breath attributed to \n",
      "lymphocytic interstitial pneumonitis (restrictive disease noted \n",
      "on PFTs ___ ___ and CT imaging notable for extensive \n",
      "ground-glass densities) associated with untreated HIV infection. \n",
      "He initially received Cefepime and Levofloxacin IV for bacterial \n",
      "pneumonia coverage. He was seen by Pulmonary and ID who felt a \n",
      "course of Prednisone 60 mg PO daily ___ addition to the \n",
      "reinitiation of HAART was appropriate. He was started on Dapsone \n",
      "for PJP ppx at that time as well. Although he presented on \n",
      "prescribed HAART therapy, his ID provider felt he was not taking \n",
      "his medications and given the concern for resistance stopped his \n",
      "regimen. He continued Levofloxacin PO for a short-course for \n",
      "empiric pneumonia coverage. He was discharged to ___ \n",
      "___ following this admission. A midline line was placed ___ \n",
      "to discharge.\n",
      "\n",
      "He returned to ___ ED on ___ from rehab and was \n",
      "admitted after he was noted to have a period of unresponsiveness \n",
      "and questionable seizure-like activity. He was unable to \n",
      "verbally communicate and appeared confused. O2 sats were 90% on \n",
      "5L NC at that time. He was also complaining of lethargy and \n",
      "increased shortness of breath.  He was also reporting trouble \n",
      "swallowing. While hospitalized, he was started on Zosyn IV 4.5g \n",
      "Q6 hours. His phenobarbital level was 7.7 (low) which was \n",
      "concerning given his presumed seizure activity. Given these \n",
      "concerns, he required intubation for airway protection. He \n",
      "underwent RSI with Etomidate 20g IV, Vercuronium 10mg IV and \n",
      "received Fentanyl 100 mcg IV and Lidocaine 130 mg IV. CT imaging \n",
      "of the head was obtained, ___ addition to a CXR. He received \n",
      "Zosyn IV 4.5g ___ to transfer. His phenobarbital level was 7.7 \n",
      "___ the ED. He was transfered to ___ following intubation for \n",
      "further evaluation and management.\n",
      "\n",
      "He has had multiple admissions to ___ for treated \n",
      "of PJP pneumonia with Atovaquone and steroids.\n",
      "\n",
      "___ the ___ ED, initial VS 97.5 ___ 18 100% (AC/CMV \n",
      "500/20/5/1.0). Outside imaging was uploaded into our system. \n",
      "Propofol gtt was started for sedation ___ the setting of \n",
      "mechanical ventilation. A repeat CXR was obtained. Neurosurgery \n",
      "was consulted given the brain mass. ABG: 7.41/40/505 (on \n",
      "500/20/5/1.0).\n",
      "\n",
      "On arrival to the MICU, patient was intubated and sedated on \n",
      "propofol. Propofol stopped and patient not waking, minimally \n",
      "responsive to commands.\n",
      "\n",
      "Review of systems:  \n",
      "(+) Per HPI  \n",
      "(-) Denies fever, chills, night sweats, recent weight loss or \n",
      "gain. Denies headache, sinus tenderness, rhinorrhea or \n",
      "congestion. Denies cough, shortness of breath, or wheezing. \n",
      "Denies chest pain, chest pressure, palpitations, or weakness. \n",
      "Denies nausea, vomiting, diarrhea, constipation, abdominal pain, \n",
      "or changes ___ bowel habits. Denies dysuria, frequency, or \n",
      "urgency. Denies arthralgias or myalgias. Denies rashes or skin \n",
      "changes.  \n",
      "\n",
      " \n",
      "Past Medical History:\n",
      "1. HIV/AIDS infection (diagnosed ___ years ___ history of OI \n",
      "and CD4 count nadir unknown. Last CD4 count was 24 and HIV VL \n",
      "greater than 1 million as of ___. On ARV regimen with poor \n",
      "compliance documented - followed by ___ from ___)\n",
      "2. History of multiple episodes of Pneumocystis pneumonia\n",
      "3. Oxygen-dependent chronic obstructive pulmonary disease\n",
      "4. ___ tobacco use\n",
      "5. History of seizures (attributed to history of Toxoplasmosis)\n",
      "6. Chronic diarrheal illness\n",
      "7. History of hypokalemia\n",
      "8. History of a right-sided burr hole\n",
      "9. Appendectomy\n",
      " \n",
      "Social History:\n",
      "___\n",
      "Family History:\n",
      "Both parents had congestive heart failure.\n",
      "\n",
      " \n",
      "Physical Exam:\n",
      "ADMISSION PHYSICAL EXAM:\n",
      "Vitals: 96.2 p82 125/84 R14 93% \n",
      "Vent: AC Vt 500 (observed 886), f14,PEEP 5, FiO2 50 \n",
      "General: Ill appearing male, intubated\n",
      "HEENT:  Mucous membs moist\n",
      "Neck: JVP difficult to assess\n",
      "CV:  S1/S2 distant, no appreciable murmurs\n",
      "Lungs: Decreased air entry on left, harsh inspiratory and \n",
      "expiratory breath sounds on right\n",
      "Abdomen: Soft, nontender, normoactive bowel sounds\n",
      "GU: foley \n",
      "Ext:  Warm no peripheral edema \n",
      "Neuro: Intubated. Examined few minutes after propofol held. Not \n",
      "opening eyes. Briefly gripped hand but otherwise not following \n",
      "commands. Pupils 1mm, ___, mildly reactive. Moves 4 \n",
      "extremities when suctioned. Downgoing Babinski\n",
      "\n",
      "DISCHARGE PHYSICAL EXAM:\n",
      "VS: 98.3 97 ___ 20 95-97%TM\n",
      "GEN: Lying ___ bed comfortably, Awake but not making eye contact. \n",
      "Trached and unable to speak\n",
      "HEENT: Unable to examine mouth secondary to patient's inability \n",
      "to open. Sclera anicteric. No LAD\n",
      "RESP: Rhonchi appreciated bilaterally from anterior evaluation\n",
      "CV: Distant heart sounds, no murmurs, rubs, gallops\n",
      "Abd: Soft,non distended, no tenderness ___ all 4 quadrants. PEG \n",
      "tube\n",
      "GU: Foley draining\n",
      "Ext: Warm, no edema. \n",
      "Neuro: Non-verbal. Can squeeze hand when asked. Moves all \n",
      "extremities. Not spontaneous making eye contact. LUE is \n",
      "contracted.  \n",
      "\n",
      " \n",
      "Pertinent Results:\n",
      "ADMISSION LABS:\n",
      "==============\n",
      "___ 11:23PM   GLUCOSE-162* UREA N-22* CREAT-0.6 SODIUM-132* \n",
      "POTASSIUM-4.3 CHLORIDE-100 TOTAL CO2-22 ANION GAP-14\n",
      "___ 11:23PM   CALCIUM-9.0 PHOSPHATE-2.8 MAGNESIUM-2.3\n",
      "___ 11:23PM   OSMOLAL-286\n",
      "___ 11:14PM   TYPE-ART PO2-209* PCO2-27* PH-7.55* TOTAL \n",
      "CO2-24 BASE XS-3\n",
      "___ 11:14PM   GLUCOSE-164* LACTATE-2.0 NA+-132* K+-4.2 \n",
      "CL--102\n",
      "___ 11:14PM   freeCa-1.14\n",
      "___ 11:04PM URINE  HOURS-RANDOM CREAT-77 SODIUM-16 \n",
      "POTASSIUM-46 CHLORIDE-37\n",
      "___ 11:04PM URINE  OSMOLAL-991\n",
      "___ 11:04PM URINE  COLOR-Yellow APPEAR-Clear SP \n",
      "___\n",
      "___ 11:04PM URINE  BLOOD-TR NITRITE-NEG PROTEIN-TR \n",
      "GLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-2* PH-6.0 LEUK-NEG\n",
      "___ 10:45PM   ___ PO2-66* PCO2-33* PH-7.48* TOTAL \n",
      "CO2-25 BASE XS-1\n",
      "___ 10:45PM   NA+-128* K+-6.2*\n",
      "___ 06:29PM   ___ PO2-72* PCO2-36 PH-7.47* TOTAL \n",
      "CO2-27 BASE XS-2 COMMENTS-GREEN-TOP\n",
      "___ 06:29PM   GLUCOSE-131* LACTATE-1.8\n",
      "___ 06:29PM   freeCa-1.00*\n",
      "___ 06:12PM   GLUCOSE-142* UREA N-23* CREAT-0.7 SODIUM-127* \n",
      "POTASSIUM-GREATER TH CHLORIDE-96 TOTAL CO2-25\n",
      "___ 06:12PM   ALT(SGPT)-161* AST(SGOT)-102* ALK PHOS-83 TOT \n",
      "BILI-1.1\n",
      "___ 06:12PM   ALBUMIN-3.6 CALCIUM-9.0 PHOSPHATE-3.8 \n",
      "MAGNESIUM-2.4\n",
      "___ 06:12PM   OSMOLAL-286\n",
      "___ 06:12PM   WBC-10.4# RBC-5.44 HGB-15.5 HCT-44.1 MCV-81* \n",
      "MCH-28.5 MCHC-35.1* RDW-15.6*\n",
      "___ 06:12PM   PLT COUNT-221\n",
      "___ 06:12PM   ___ PTT-25.5 ___\n",
      "___ 05:07PM   TYPE-ART PO2-96 PCO2-31* PH-7.49* TOTAL \n",
      "CO2-24 BASE XS-1\n",
      "___ 05:07PM   LACTATE-1.6\n",
      "___ 05:07PM   O2 SAT-95\n",
      "___ 03:30PM   TYPE-ART PO2-148* PCO2-33* PH-7.48* TOTAL \n",
      "CO2-25 BASE XS-2\n",
      "___ 03:30PM   O2 SAT-96\n",
      "___ 01:52PM   SODIUM-130*\n",
      "___ 01:52PM   OSMOLAL-QNS\n",
      "___ 09:51AM URINE  COLOR-Yellow APPEAR-Clear SP ___\n",
      "___ 09:51AM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-30 \n",
      "GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-2* PH-6.0 LEUK-NEG\n",
      "___ 09:51AM URINE  RBC-59* WBC-2 BACTERIA-NONE YEAST-NONE \n",
      "EPI-0\n",
      "___ 09:51AM URINE  MUCOUS-OCC\n",
      "___ 06:59AM   TYPE-ART PO2-192* PCO2-40 PH-7.44 TOTAL \n",
      "CO2-28 BASE XS-3\n",
      "___ 06:59AM   LACTATE-1.1\n",
      "___ 05:56AM   GLUCOSE-131* UREA N-22* CREAT-0.5 SODIUM-133 \n",
      "POTASSIUM-3.8 CHLORIDE-98 TOTAL CO2-25 ANION GAP-14\n",
      "___ 05:56AM   ALT(SGPT)-150* AST(SGOT)-57* LD(LDH)-320* ALK \n",
      "PHOS-103 TOT BILI-1.0\n",
      "___ 05:56AM   CALCIUM-8.8 PHOSPHATE-3.9 MAGNESIUM-2.0\n",
      "___ 05:56AM   HBsAg-NEGATIVE HBs Ab-NEGATIVE HBc \n",
      "Ab-NEGATIVE\n",
      "___ 05:56AM   HCV Ab-NEGATIVE\n",
      "___ 05:56AM   WBC-4.7 RBC-5.93 HGB-16.7 HCT-48.1 MCV-81* \n",
      "MCH-28.2 MCHC-34.7 RDW-15.2\n",
      "___ 05:56AM   PLT COUNT-204\n",
      "___ 05:56AM    WBC-4.7  LYMPH-8* ABS LYMPH-376 CD3-65 ABS \n",
      "CD3-245* CD4-3 ABS CD4-12* CD8-61 ABS CD8-230 CD4/CD8-0.1*\n",
      "___ 01:32AM   TYPE-ART RATES-/2  TIDAL VOL-300 PEEP-5 \n",
      "O2-100 PO2-505* PCO2-40 PH-7.41 TOTAL CO2-26 BASE XS-1 AADO2-169 \n",
      "REQ O2-38 INTUBATED-INTUBATED\n",
      "___ 01:32AM   O2 SAT-98\n",
      "___ 01:20AM URINE  HOURS-RANDOM\n",
      "___ 01:20AM URINE  bnzodzpn-NEG barbitrt-POS opiates-NEG \n",
      "cocaine-NEG amphetmn-NEG mthdone-NEG\n",
      "___ 01:20AM URINE  COLOR-Yellow APPEAR-Clear SP ___\n",
      "___ 01:20AM URINE  BLOOD-SM  NITRITE-NEG PROTEIN-100 \n",
      "GLUCOSE-NEG KETONE-10 BILIRUBIN-NEG UROBILNGN-2* PH-6.0 LEUK-NEG\n",
      "___ 01:20AM URINE  RBC-9* WBC-4 BACTERIA-FEW YEAST-NONE \n",
      "EPI-<1\n",
      "___ 01:20AM URINE  HYALINE-6*\n",
      "___ 01:20AM URINE  MUCOUS-RARE\n",
      "___ 01:04AM   PH-7.41 COMMENTS-GREEN TOP \n",
      "___ 01:04AM   GLUCOSE-155* LACTATE-1.8 NA+-135 K+-3.9 \n",
      "CL--101 TCO2-22\n",
      "___ 01:04AM   HGB-16.4 calcHCT-49 O2 SAT-95 CARBOXYHB-3 MET \n",
      "HGB-0\n",
      "___ 01:04AM   freeCa-1.03*\n",
      "___ 12:50AM   GLUCOSE-161* UREA N-20 CREAT-0.9 SODIUM-131* \n",
      "POTASSIUM-6.3* CHLORIDE-98 TOTAL CO2-20* ANION GAP-19\n",
      "___ 12:50AM   estGFR-Using this\n",
      "___ 12:50AM   ALT(SGPT)-134* AST(SGOT)-101* ALK PHOS-95 TOT \n",
      "BILI-1.2\n",
      "___ 12:50AM   LIPASE-36\n",
      "___ 12:50AM   ALBUMIN-3.8\n",
      "___ 12:50AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG \n",
      "bnzodzpn-NEG barbitrt-NEG tricyclic-NEG\n",
      "___ 12:50AM   WBC-6.1 RBC-6.07 HGB-16.0 HCT-50.3 MCV-83 \n",
      "MCH-26.3* MCHC-31.7 RDW-15.4\n",
      "___ 12:50AM   NEUTS-88.4* LYMPHS-9.1* MONOS-1.6* EOS-0.4 \n",
      "BASOS-0.5\n",
      "___ 12:50AM   ___ PTT-29.2 ___\n",
      "___ 12:50AM   PLT COUNT-223\n",
      "___ 12:50AM   ___\n",
      "\n",
      "BLOOD SPECIMEN SEND OUTS:\n",
      "========================\n",
      "___ B-GLUCAN Test                        \n",
      "----                       \n",
      "Fungitell (tm) Assay for (1,3)-B-D-Glucans\n",
      " \n",
      "Results                                 Reference Ranges\n",
      "-------                                 ----------------\n",
      "Not Result*                             Negative       Less than \n",
      "60 pg/mL\n",
      "                                        Indeterminate  60 - 79 \n",
      "pg/mL\n",
      "                                        Positive       Greater \n",
      "than or \n",
      "                                                       ___ to \n",
      "80 pg/mL\n",
      "\n",
      "___ 04:10 B-GLUCAN \n",
      "  Test                        \n",
      "----                       \n",
      "Fungitell (tm) Assay for (1,3)-B-D-Glucans\n",
      " \n",
      "Results                                 Reference Ranges\n",
      "-------                                 ----------------\n",
      "65 pg/mL                                Negative       Less than \n",
      "60 pg/mL\n",
      "                                        Indeterminate  60 - 79 \n",
      "pg/mL\n",
      "                                        Positive       Greater \n",
      "than or ___ to\n",
      "                                                       80 pg/mL\n",
      "\n",
      " \n",
      "___ ASPERGILLUS GALACTOMANNAN ANTIGEN \n",
      "  Test                          Result              Reference \n",
      "Range/Units\n",
      "INDEX VALUE                   7.19  H             <0.50\n",
      "ASPERGILLUS AG,EIA,SERUM      Detected  A         Not Detected\n",
      "   \n",
      "___ ASPERGILLUS GALACTOMANNAN ANTIGEN \n",
      "  Test                          Result              Reference \n",
      "Range/Units\n",
      "INDEX VALUE                   7.19  H             <0.50\n",
      "ASPERGILLUS AG,EIA,SERUM      Detected  A         Not Detected\n",
      "\n",
      "IMAGING:\n",
      "========\n",
      "___ EEG:\n",
      "FINDINGS: \n",
      "ABNORMALITY #1: Throughout most of the recording, the background \n",
      "rhythm was slow and mildly disorganized at about 7 Hz ___ both \n",
      "posterior regions. \n",
      "ABNORMALITY #2: There were bursts of delta slowing ___ the left \n",
      "hemisphere, \n",
      "more ___ the temporal region. \n",
      "ABNORMALITY #3: There were independent bursts of mixed frequency \n",
      "slowing ___ the right frontal region and hemisphere. \n",
      "HYPERVENTILATION: Could not be performed. \n",
      "INTERMITTENT PHOTIC STIMULATION: Could not be performed. \n",
      "SLEEP: The patient appeared to remain awake throughout the \n",
      "recording. \n",
      "CARDIAC MONITOR: Showed a generally regular rhythm. \n",
      "IMPRESSION: Abnormal extended routine EEG due to a mildly slow \n",
      "background and the bilateral areas of intermittent focal \n",
      "slowing. Any slow background \n",
      "indicates a mild to moderate encephalopathy. The focal slowing \n",
      "indicates \n",
      "areas of subcortical dysfunction bilaterally. It does not \n",
      "specify the \n",
      "etiology. There were no epileptiform features or electrographic \n",
      "seizures. \n",
      "\n",
      "___ CXR:\n",
      "IMPRESSION:   \n",
      "1.  Acute pulmonary edema, significantly worsened compared with \n",
      "radiograph performed two hours ___ to this exam, on the \n",
      "background of bibasilar interstitial lung disease. \n",
      "2.  Endotracheal tube ends 9 mm above the carina.  Withdrawal of \n",
      "approximately 2 cm is recommended for proper placement. \n",
      "3.  9 mm discrepancy between the caliber of the balloon of the \n",
      "EET and the caliber of the distal trachea. \n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  ___ comparison with the earlier study of this date, \n",
      "the endotracheal tube has been pulled back so that the tip now \n",
      "lies approximately 2.2 cm above the carina.  Nasogastric tube \n",
      "extends at least to the lower body of the stomach where it \n",
      "crosses the lower margin of the image. There are lower lung \n",
      "volumes.  Diffuse prominence of interstitial markings reflects a \n",
      "combination of interstitial fibrosis and pulmonary edema. \n",
      "\n",
      "___ CXR:\n",
      "IMPRESSION: \n",
      "1.  Midline catheter with tip overlying the right axilla. \n",
      "2.  New moderate pulmonary edema. \n",
      "3.  Left basilar opacity. Pneumonia cannot be excluded ___ the \n",
      "correct clinical setting. \n",
      "\n",
      "___ RUQ ULTRASOUND:\n",
      "IMPRESSION: \n",
      "1.  Limited portable exam, however, no obvious hepatic lesions.  \n",
      "Patent portal vein with normal hepatopetal flow. \n",
      "2.  Splenomegaly. \n",
      "3.  Multiple gallbladder stones and tumefactive sludge without \n",
      "evidence of acute cholecystitis.  Normal caliber biliary tree. \n",
      "4.  Incidental note of simple appearing left renal cyst. \n",
      "\n",
      "___ MRI BRAIN:\n",
      "IMPRESSION: \n",
      "1.  Heterogeneously-enhancing lesions with prominent slow \n",
      "diffusion ___ the left temporal lobe, left basal ganglia and \n",
      "right frontal lobe with significant associated vasogenic edema.  \n",
      " \n",
      "  \n",
      "The findings are most suggestive of CNS lymphoma, though at \n",
      "least a portion of the dominant lesion has a \"targetoid\" \n",
      "appearance characteristic of toxoplasmosis.  The imaging \n",
      "findings are quite atypical for pyogenic abscess, and PML, and \n",
      "___ particular, ___ would be a far more remote \n",
      "consideration, given the history of non-compliance.   \n",
      "  \n",
      "2.  Additional small foci of restricted diffusion, some of which \n",
      "show faint ___ represent additional \n",
      "intravascular involvement by lymphoma.   Alternatively, these \n",
      "may represent septic emboli, if there is a source, or even \n",
      "\"bland\" infarcts, given the ___ right basal ganglionic \n",
      "infarct. \n",
      "  \n",
      "3.  Subfalcine and very early left uncal herniation, unchanged \n",
      "___ degree from CT ___. \n",
      "  \n",
      "COMMENT:  Preliminary findings of subfalcine and early uncal \n",
      "herniation were discussed with Dr. ___ (___ resident) \n",
      "at 2:05 p.m. on ___, at the time of discovery. \n",
      "\n",
      "___ CXR:\n",
      "INDINGS:  ___ comparison with the earlier study of this date, \n",
      "there has been placement of a left subclavian PICC line that \n",
      "extends to the lower portion of the SVC.  Otherwise, there is \n",
      "little change ___ the moderate pulmonary edema, with supervening \n",
      "pneumonia difficult to exclude ___ the appropriate clinical \n",
      "setting. \n",
      "\n",
      "___ CT HEAD\n",
      "IMPRESSION:  Since the ___ MRI, a stereotactic frame has been \n",
      "placed.  \n",
      "Multiple enhancing lesions, the largest ___ the left basal \n",
      "ganglia, are better \n",
      "characterized on the ___ MRI and not changed.  There is \n",
      "persistent rightward \n",
      "shift of the normally midline structures and effacement of the \n",
      "perimesencephalic cistern. \n",
      "\n",
      "___ CT HEAD W/O CONTRAST:\n",
      "IMPRESSION: \n",
      "1.  Post operative changes from left sided lesion biopsy, \n",
      "without \n",
      "pneumocephalus or blood products seen ___ the biopsy tract. \n",
      "2.  No significant interval change ___ the other bilateral \n",
      "lesions with \n",
      "significant surrounding vasogenic edema, resulting mass effect \n",
      "and 8mm of \n",
      "midline shift to the right. \n",
      "3.  Mild dilatation of the right ventricle is stable from ___ \n",
      "MR. \n",
      "___ and coarse calcifications at the level of the \n",
      "right basal \n",
      "ganglia and internal capsule were seen ___ ___. \n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  Single semi-erect AP portable view of the chest was \n",
      "obtained.  \n",
      "Endotracheal tube is seen, terminating approximately 3.7 cm \n",
      "above the level of the carina.  An enteric tube is seen coursing \n",
      "below the level of the diaphragm, inferior aspect not well seen. \n",
      " A left-sided PICC is seen, stable ___ position.  There are low \n",
      "lung volumes.  Pulmonary edema persists.  There is no \n",
      "pneumothorax.  No large pleural effusions. \n",
      "  \n",
      "IMPRESSION:  No significant interval change.\n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  Comparison is made to the previous study from ___. \n",
      "  There is an endotracheal tube whose tip is 3.8 cm below the \n",
      "carina, \n",
      "appropriately sited.  There are again seen diffuse airspace \n",
      "opacities \n",
      "bilaterally.  There are low lung volumes.  The heart size is \n",
      "within normal limits.  There is a left-sided PICC line with \n",
      "distal lead tip ___ the mid SVC.  No pneumothoraces are seen. \n",
      " \n",
      "___ CXR:\n",
      "FINDINGS:  Comparison is made to previous study from ___. \n",
      "  There is improvement of the consolidation throughout both lung \n",
      "fields, \n",
      "particularly at the lung bases.  Endotracheal tube and \n",
      "left-sided PICC line are unchanged ___ position and appropriately \n",
      "sited.  There are low lung volumes due to poor inspiratory \n",
      "effort \n",
      "\n",
      "___ CXR\n",
      "FINDINGS:  Comparison is made to ___ study from ___. \n",
      "\n",
      "  \n",
      "Endotracheal tube, left-sided PICC line and an enteric tube are \n",
      "unchanged ___ position.  Areas of consolidation throughout both \n",
      "lung fields continue to improve.  There remains areas of \n",
      "increased density within the lung bases.  There are no \n",
      "pneumothoraces or pleural effusions. \n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  Indwelling support and monitoring devices are ___ \n",
      "standard position. Lung volumes are low, accentuating the \n",
      "cardiac silhouette and bronchovascular markings.  With this \n",
      "limitation ___ mind, widespread ground-glass and reticular \n",
      "opacities are relatively similar to the ___ chest x-ray and \n",
      "have been documented on older chest CT of ___.  \n",
      "Given apparent chronicity of an HIV status, chronic PCP should \n",
      "be considered.  A more confluent area of opacity ___ the left \n",
      "infrahilar region has increased compared to the recent \n",
      "radiograph, and raises the possibility of a superimposed \n",
      "bacterial pneumonia ___ the appropriate clinical setting.  There \n",
      "is no evidence of pneumothorax or substantial pleural effusion. \n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  As compared to the previous radiograph, there is no \n",
      "relevant \n",
      "change.  The lung volumes are low, despite intubation.  Normal \n",
      "position of nasogastric tube.  Borderline size of the cardiac \n",
      "silhouette.  Diffuse reticular nodular opacities ___ both lungs, \n",
      "raising concern for chronic PCP. No pleural effusions.  No new \n",
      "parenchymal opacities as compared to the previous examination.\n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  As compared to the previous radiograph, there is no \n",
      "relevant \n",
      "change.  The extensive parenchymal opacities ___ both lungs are \n",
      "constant ___ appearance.  The lung volumes remain low.  Unchanged \n",
      "borderline size of the cardiac silhouette.  Unchanged monitoring \n",
      "and support devices.  No pleural effusions. \n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  As compared to the previous image, the nasogastric \n",
      "tube has been changed.  Course of the new tube is unremarkable, \n",
      "the tip, however, is not visualized on the current image.  The \n",
      "diffuse parenchymal changes are constant ___ appearance.  The \n",
      "lung volumes remain low.  ___ the interval, the patient has been \n",
      "extubated, but the left PICC line remains ___ situ.  No evidence \n",
      "of pneumothorax or other complications. \n",
      "\n",
      "___ CXR:\n",
      "IMPRESSION:  Unchanged coarse reticular basilar-predominant \n",
      "opacities on \n",
      "background of diffuse ground glass opacification. This may \n",
      "represent chronic PCP or ___ diffuse fibrotic lung disease such as \n",
      "NSIP. No evidence of Superimposed acute process.  \n",
      "\n",
      "___ CXR:\n",
      "FINDINGS:  ___ comparison with study of ___, there are continued \n",
      "low lung \n",
      "volumes.  Areas of increased opacification are again seen \n",
      "bilaterally, \n",
      "especially at the bases.  Again, this could reflect chronic \n",
      "inflammatory or fibrotic lung disease with some atelectatic \n",
      "changes.  ___ the appropriate clinical setting, some acute \n",
      "element of infection would be difficult to exclude.\n",
      "\n",
      "___ MR HEAD W & W/O CONTRAST:\n",
      "IMPRESSION:  Redemonstration of multiple abnormal enhancing \n",
      "intracranial \n",
      "lesions as above, with interval decrease ___ the size of many of \n",
      "the lesions and decrease ___ the extent of mass effect.  There is \n",
      "no new or enlarging focus of abnormal enhancement.   \n",
      "\n",
      "___ CHEST (PORTABLE AP):\n",
      "FINDINGS:  Tracheostomy tube and left PICC remain ___ standard \n",
      "position, and cardiomediastinal contours are normal.  Diffuse \n",
      "interstitial lung disease with associated low lung volumes \n",
      "appear similar compared to ___ studies, with no superimposed \n",
      "acute process evident. \n",
      "\n",
      "___ CHEST (PORTABLE AP):\n",
      "FINDINGS:  ___ comparison with the study of ___, obliquity of the \n",
      "patient \n",
      "somewhat obscures detail.  There again are low lung volumes with \n",
      "diffuse \n",
      "interstitial lung disease.  Monitoring and support devices \n",
      "remain ___ place. \n",
      "\n",
      "___ CT ABD & PELVIS W/O CON\n",
      "IMPRESSION: Small amount of intraperitoneal free air anterior to \n",
      "the liver.  On review of the OMR, it is noted that the patient \n",
      "recently had a percutaneous gastrostomy tube placed on ___.  Although it is possible that the intraperitoneal free air \n",
      "is related to that procedure, clinical correlation is advised. \n",
      "No radiopaque urinary tract calculi.  No hydronephrosis or \n",
      "hydroureter. Cholelithiasis. Extensive ground-glass change \n",
      "within both lung bases, highly concerning for atypical \n",
      "pneumonia.  Bilateral femoral head AVN \n",
      "\n",
      "MICROBIOLOGY:\n",
      "============\n",
      "___ 11:22 am SEROLOGY/BLOOD      Source: Venipuncture. \n",
      "   CRYPTOCOCCAL ANTIGEN (Final ___: \n",
      "      CRYPTOCOCCAL ANTIGEN NOT DETECTED. \n",
      "         \n",
      "___ 11:30 am IMMUNOLOGY      Source: Venipuncture. \n",
      "   HIV-1 Viral Load/Ultrasensitive (Final ___: \n",
      "      244 copies/ml. \n",
      "   \n",
      "___ 11:22 am URINE      Source: Catheter. \n",
      "   Legionella Urinary Antigen  (Final ___: \n",
      "      NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. \n",
      "           \n",
      "\n",
      "___ 8:06 pm BIOPSY     Site: BRAIN\n",
      "      LATERAL BRAIN BX R/O HSV AND CMV (SHELL VIAL). \n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \n",
      "LEUKOCYTES. \n",
      "      NO MICROORGANISMS SEEN. \n",
      "\n",
      "   TISSUE (Final ___:    NO GROWTH. \n",
      "\n",
      "   ANAEROBIC CULTURE (Final ___:    NO GROWTH. \n",
      "\n",
      "   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. \n",
      "\n",
      "   POTASSIUM HYDROXIDE PREPARATION (Final ___: \n",
      "      NO FUNGAL ELEMENTS SEEN. \n",
      "\n",
      "   ACID FAST SMEAR (Final ___: \n",
      "      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. \n",
      "\n",
      "   ACID FAST CULTURE (Preliminary):    NO MYCOBACTERIA ISOLATED. \n",
      "\n",
      "\n",
      "   VIRAL CULTURE (Preliminary):    NO VIRUS ISOLATED. \n",
      "\n",
      "   NOCARDIA CULTURE (Preliminary):    NO NOCARDIA ISOLATED. \n",
      "\n",
      "   CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Final \n",
      "___: \n",
      "      Negative for Cytomegalovirus early antigen by \n",
      "immunofluorescence. \n",
      "      Refer to culture results for further information. \n",
      "___ 8:06 pm BIOPSY     Site: BRAIN\n",
      "      MEDIAL BRAIN BX R/O HSV, EBV, CMV (SHELL VIAL). \n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \n",
      "LEUKOCYTES. \n",
      "      NO MICROORGANISMS SEEN. \n",
      "\n",
      "   TISSUE (Final ___: \n",
      "      Reported to and read back by ___ ___ \n",
      "2:50PM. \n",
      "      VIRIDANS STREPTOCOCCI.    2 COLONIES. \n",
      "         CLINICAL SIGNIFICANCE UNCERTAIN. \n",
      "\n",
      "   ANAEROBIC CULTURE (Final ___:    NO ANAEROBES ISOLATED. \n",
      "\n",
      "\n",
      "   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. \n",
      "\n",
      "   POTASSIUM HYDROXIDE PREPARATION (Final ___: \n",
      "      NO FUNGAL ELEMENTS SEEN. \n",
      "\n",
      "   ACID FAST SMEAR (Final ___: \n",
      "      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. \n",
      "\n",
      "   ACID FAST CULTURE (Preliminary):    NO MYCOBACTERIA ISOLATED. \n",
      "\n",
      "\n",
      "   VIRAL CULTURE (Preliminary):    NO VIRUS ISOLATED. \n",
      "\n",
      "   NOCARDIA CULTURE (Preliminary):    NO NOCARDIA ISOLATED. \n",
      "\n",
      "   CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Final \n",
      "___: \n",
      "      Negative for Cytomegalovirus early antigen by \n",
      "immunofluorescence. \n",
      "      Refer to culture results for further information. \n",
      "\n",
      "___ 10:01 pm STOOL     CONSISTENCY: NOT APPLICABLE\n",
      "      Source: Stool. \n",
      "\n",
      "                            **FINAL REPORT ___\n",
      "\n",
      "   C. difficile DNA amplification assay (Final ___: \n",
      "      Negative for toxigenic C. difficile by the Illumigene DNA\n",
      "      amplification assay. \n",
      "           (Reference Range-Negative). \n",
      "\n",
      "___ 8:35 am SEROLOGY/BLOOD      CHEM# ___ ___. \n",
      "\n",
      "                            **FINAL REPORT ___\n",
      "\n",
      "   RAPID PLASMA REAGIN TEST (Final ___: \n",
      "      NONREACTIVE. \n",
      "      Reference Range: Non-Reactive. \n",
      "\n",
      "___ 4:22 pm BRONCHOALVEOLAR LAVAGE      BRONCHIAL LAVAGE. \n",
      "      HSV CULTURE ADDED PER ADD-ON ___. \n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      1+    (<1 per 1000X FIELD):   POLYMORPHONUCLEAR \n",
      "LEUKOCYTES. \n",
      "      NO MICROORGANISMS SEEN. \n",
      "\n",
      "   RESPIRATORY CULTURE (Final ___: \n",
      "      ~1000/ML Commensal Respiratory Flora. \n",
      "\n",
      "   LEGIONELLA CULTURE (Final ___:    NO LEGIONELLA \n",
      "ISOLATED. \n",
      "\n",
      "   POTASSIUM HYDROXIDE PREPARATION (Final ___: \n",
      "      TEST CANCELLED, PATIENT CREDITED. \n",
      "      This is a low yield procedure based on our ___ \n",
      "studies. \n",
      "      if pulmonary Histoplasmosis, Coccidioidomycosis, \n",
      "Blastomycosis,\n",
      "      Aspergillosis or Mucormycosis is strongly suspected, \n",
      "contact the\n",
      "      Microbiology Laboratory (___). \n",
      "\n",
      "   Immunoflourescent test for Pneumocystis jirovecii (carinii) \n",
      "(Final\n",
      "      ___:    NEGATIVE for Pneumocystis jirovecii \n",
      "(carinii).. \n",
      "\n",
      "   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. \n",
      "\n",
      "   NOCARDIA CULTURE (Preliminary):    NO NOCARDIA ISOLATED. \n",
      "\n",
      "   ACID FAST SMEAR (Final ___: \n",
      "      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. \n",
      "\n",
      "   ACID FAST CULTURE (Preliminary):    NO MYCOBACTERIA ISOLATED. \n",
      "\n",
      "\n",
      "   VIRAL CULTURE: R/O CYTOMEGALOVIRUS (Final ___: \n",
      "      TEST CANCELLED, PATIENT CREDITED. \n",
      "      Refer to ___ early antigen test result for further \n",
      "information. \n",
      "\n",
      "   CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) (Final \n",
      "___: \n",
      "      POSITIVE FOR CYTOMEGALOVIRUS. \n",
      "         Early antigen detected by immunofluorescence. \n",
      "         Reported to and read back by ___ 2:09PM. \n",
      "\n",
      "   VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS (Final ___: \n",
      "      HERPES SIMPLEX VIRUS TYPE 1. \n",
      "         CONFIRMED BY MONOCLONAL FLUORESCENT ANTIBODY.. \n",
      "\n",
      "___ 7:49 am SPUTUM      Source: Endotracheal. \n",
      "   GRAM STAIN (Final ___: \n",
      "      ___ PMNs and <10 epithelial cells/100X field. \n",
      "      1+    (<1 per 1000X FIELD):   BUDDING YEAST. \n",
      "\n",
      "   RESPIRATORY CULTURE (Final ___: \n",
      "      Commensal Respiratory Flora Absent. \n",
      "      YEAST.    SPARSE GROWTH. \n",
      "\n",
      "   FUNGAL CULTURE (Preliminary): \n",
      "      YEAST. \n",
      "\n",
      "___ 11:00 pm Immunology (CMV)      Source: Venipuncture. \n",
      "\n",
      "                            **FINAL REPORT ___\n",
      "\n",
      "   CMV Viral Load (Final ___: \n",
      "      438 IU/mL. \n",
      "      Performed by Cobas Ampliprep / Cobas Taqman CMV Test. \n",
      "      Linear range of quantification: 137 IU/mL - 9,100,000 \n",
      "IU/mL. \n",
      "      Limit of detection 91 IU/mL. \n",
      "      This test has been verified for use ___ the ___ patient \n",
      "population. \n",
      "      Reported to and read back by ___ (CC6D) ___ AT \n",
      "1024. \n",
      "\n",
      "___ 4:25 pm SPUTUM      Source: Endotracheal ENDOTRACHEAL. \n",
      "\n",
      "                            **FINAL REPORT ___\n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      >25 PMNs and <10 epithelial cells/100X field. \n",
      "      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. \n",
      "                                    ___ AND ___ PAIRS. \n",
      "\n",
      "   RESPIRATORY CULTURE (Final ___: \n",
      "      RARE GROWTH Commensal Respiratory Flora. \n",
      "      STAPH AUREUS COAG +.    RARE GROWTH. \n",
      "         Oxacillin RESISTANT Staphylococci MUST be reported as \n",
      "also\n",
      "         RESISTANT to other penicillins, cephalosporins, \n",
      "carbacephems,\n",
      "         carbapenems, and beta-lactamase inhibitor combinations. \n",
      "\n",
      "         Rifampin should not be used alone for therapy. \n",
      "         SULFA X TRIMETH sensitivity testing confirmed by ___ \n",
      "___. \n",
      "\n",
      "___ 11:00 pm SPUTUM      Source: Endotracheal. \n",
      "\n",
      "                            **FINAL REPORT ___\n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      >25 PMNs and <10 epithelial cells/100X field. \n",
      "      2+   ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n",
      "      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. \n",
      "                                    ___ PAIRS AND CLUSTERS. \n",
      "      1+    (<1 per 1000X FIELD):   BUDDING YEAST. \n",
      "      SMEAR REVIEWED; RESULTS CONFIRMED. \n",
      "\n",
      "   RESPIRATORY CULTURE (Final ___: \n",
      "      SPARSE GROWTH Commensal Respiratory Flora. \n",
      "      STAPH AUREUS COAG +.    SPARSE GROWTH. \n",
      "         Oxacillin RESISTANT Staphylococci MUST be reported as \n",
      "also\n",
      "         RESISTANT to other penicillins, cephalosporins, \n",
      "carbacephems,\n",
      "         carbapenems, and beta-lactamase inhibitor combinations. \n",
      "\n",
      "         Rifampin should not be used alone for therapy. \n",
      "         SULFA X TRIMETH sensitivity testing confirmed by ___ \n",
      "___.  \n",
      "\n",
      "___ 12:45 pm BRONCHOALVEOLAR LAVAGE\n",
      "      RIGHT MIDDLE LOBE AFB FOR ATYPICAL MYCOBACTERIA. \n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      4+   (>10 per 1000X FIELD):   POLYMORPHONUCLEAR \n",
      "LEUKOCYTES. \n",
      "      2+   ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n",
      "      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. \n",
      "                                    ___ PAIRS AND ___. \n",
      "      SMEAR REVIEWED; RESULTS CONFIRMED. \n",
      "\n",
      "   RESPIRATORY CULTURE (Final ___: \n",
      "      10,000-100,000 ORGANISMS/ML. Commensal Respiratory Flora. \n",
      "      STAPH AUREUS COAG +.    10,000-100,000 ORGANISMS/ML.. \n",
      "         SENSITIVITIES PERFORMED ON CULTURE # ___ ___. \n",
      "\n",
      "   Immunoflourescent test for Pneumocystis jirovecii (carinii) \n",
      "(Final\n",
      "      ___:    NEGATIVE for Pneumocystis jirovecii \n",
      "(carinii).. \n",
      "\n",
      "   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. \n",
      "\n",
      "   ACID FAST SMEAR (Final ___: \n",
      "      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. \n",
      "      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. \n",
      "\n",
      "   ACID FAST CULTURE (Preliminary): \n",
      "\n",
      "   VIRAL CULTURE: R/O CYTOMEGALOVIRUS (Preliminary): \n",
      "      No Cytomegalovirus (CMV) isolated. \n",
      "\n",
      "   VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS (Preliminary): \n",
      "      No Herpes simplex (HSV) virus isolated. \n",
      "\n",
      "   CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) \n",
      "(Pending): \n",
      "___ 12:45 pm BRONCHOALVEOLAR LAVAGE\n",
      "      RIGHT MIDDLE LOBE AFB FOR ATYPICAL MYCOBACTERIA. \n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      4+   (>10 per 1000X FIELD):   POLYMORPHONUCLEAR \n",
      "LEUKOCYTES. \n",
      "      2+   ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n",
      "      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. \n",
      "                                    ___ PAIRS AND ___. \n",
      "      SMEAR REVIEWED; RESULTS CONFIRMED. \n",
      "\n",
      "   RESPIRATORY CULTURE (Final ___: \n",
      "      10,000-100,000 ORGANISMS/ML. Commensal Respiratory Flora. \n",
      "      STAPH AUREUS COAG +.    10,000-100,000 ORGANISMS/ML.. \n",
      "         SENSITIVITIES PERFORMED ON CULTURE # ___ ___. \n",
      "\n",
      "   Immunoflourescent test for Pneumocystis jirovecii (carinii) \n",
      "(Final\n",
      "      ___:    NEGATIVE for Pneumocystis jirovecii \n",
      "(carinii).. \n",
      "\n",
      "   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. \n",
      "\n",
      "   ACID FAST SMEAR (Final ___: \n",
      "      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. \n",
      "      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. \n",
      "\n",
      "   ACID FAST CULTURE (Preliminary): \n",
      "\n",
      "   VIRAL CULTURE: R/O CYTOMEGALOVIRUS (Preliminary): \n",
      "      No Cytomegalovirus (CMV) isolated. \n",
      "\n",
      "   VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS (Preliminary): \n",
      "      No Herpes simplex (HSV) virus isolated. \n",
      "\n",
      "   CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) \n",
      "(Pending): \n",
      "___ 12:45 pm BRONCHOALVEOLAR LAVAGE\n",
      "      RIGHT MIDDLE LOBE AFB FOR ATYPICAL MYCOBACTERIA. \n",
      "\n",
      "   GRAM STAIN (Final ___: \n",
      "      4+   (>10 per 1000X FIELD):   POLYMORPHONUCLEAR \n",
      "LEUKOCYTES. \n",
      "      2+   ___ per 1000X FIELD):   GRAM NEGATIVE ROD(S). \n",
      "      1+    (<1 per 1000X FIELD):   GRAM POSITIVE COCCI. \n",
      "                                    ___ PAIRS AND ___. \n",
      "      SMEAR REVIEWED; RESULTS CONFIRMED. \n",
      "\n",
      "   RESPIRATORY CULTURE (Final ___: \n",
      "      10,000-100,000 ORGANISMS/ML. Commensal Respiratory Flora. \n",
      "      STAPH AUREUS COAG +.    10,000-100,000 ORGANISMS/ML.. \n",
      "         SENSITIVITIES PERFORMED ON CULTURE # ___ ___. \n",
      "\n",
      "   Immunoflourescent test for Pneumocystis jirovecii (carinii) \n",
      "(Final\n",
      "      ___:    NEGATIVE for Pneumocystis jirovecii \n",
      "(carinii).. \n",
      "\n",
      "   FUNGAL CULTURE (Preliminary):    NO FUNGUS ISOLATED. \n",
      "\n",
      "   ACID FAST SMEAR (Final ___: \n",
      "      NO ACID FAST BACILLI SEEN ON DIRECT SMEAR. \n",
      "      NO ACID FAST BACILLI SEEN ON CONCENTRATED SMEAR. \n",
      "\n",
      "   ACID FAST CULTURE (Preliminary): \n",
      "\n",
      "   VIRAL CULTURE: R/O CYTOMEGALOVIRUS (Preliminary): \n",
      "      No Cytomegalovirus (CMV) isolated. \n",
      "\n",
      "   VIRAL CULTURE: R/O HERPES SIMPLEX VIRUS (Preliminary): \n",
      "      No Herpes simplex (HSV) virus isolated. \n",
      "\n",
      "   CYTOMEGALOVIRUS EARLY ANTIGEN TEST (SHELL VIAL METHOD) \n",
      "(Pending): \n",
      "\n",
      "___ 3:53 am STOOL     CONSISTENCY: NOT APPLICABLE\n",
      "      Source: Stool. \n",
      "\n",
      "                            **FINAL REPORT ___\n",
      "\n",
      "   C. difficile DNA amplification assay (Final ___: \n",
      "      Negative for toxigenic C. difficile by the Illumigene DNA\n",
      "      amplification assay. \n",
      "           (Reference Range-Negative). \n",
      "\n",
      "Discharge Labs:\n",
      " \n",
      "___ 06:27AM BLOOD WBC-10.2 RBC-4.10* Hgb-12.1* Hct-34.5* \n",
      "MCV-84 MCH-29.5 MCHC-35.1* RDW-17.8* Plt ___\n",
      "___ 06:27AM BLOOD Glucose-88 UreaN-22* Creat-0.6 Na-136 \n",
      "K-4.0 Cl-95* HCO3-28 AnGap-17\n",
      "___ 06:27AM BLOOD Calcium-8.9 Phos-4.6* Mg-2.0\n",
      "\n",
      " \n",
      "Brief Hospital Course:\n",
      "PRIMARY REASON FOR ADMISSION:\n",
      "___ with HIV/AIDS, last CD4 count 24, recent admission for \n",
      "respiratory distress and treated for Lymphocytic interstitial \n",
      "pneumonitis and pneumonia returned with worsening SOB, \n",
      "complicated by episode of unresponsiveness and worsening \n",
      "lethargy requiring intubation for airway protection. Now \n",
      "transferred to ___ after CT scan showed new brain mass with \n",
      "reported vasogenic edema, effacement, and midline shift.\n",
      ". \n",
      "ACTIVE ISSUES:\n",
      "# Toxoplasmosis: Given CD count <50, concern for opportunistic \n",
      "infection or AIDS related malignancy. Initially started \n",
      "Vancomycin, Cefepime, and Flagyl at CNS doses for coverage of \n",
      "bacterial CNS infection. Toxo coverage of Pyrimethamine and \n",
      "Clindamycin added on ___. Patient continued on Dexamethasone \n",
      "4mg Q6H initially and held ___ to biopsy. Started on Propofol, \n",
      "Keppra, and Phenobarbital for seizure prophylaxis. MRI on \n",
      "___ showed multiple ring enhancing with evidence \n",
      "of uncal herniation and midline shift similar to previous CT. On \n",
      "the afternoon of ___ patient's pupils became more dilated, \n",
      "assymetric L>R, still responsive. Head of bed elevated, \n",
      "hyperventilated to goal PCO2 of 30. Mannitol 50mg IV bolus \n",
      "given. ID, Neurology, and Neurosurgery were consulted. ID \n",
      "recommended the following infectious disease workup: CSF fluid \n",
      "studies: ___ virus PCR, toxo PCR, EBV PCR, CMV PCR, HSV PCR, TB \n",
      "PCR. No CSF was obtained ___ the biopsy and LP was not performed \n",
      "due to increased ICP and concern for herniation. Gram stain on \n",
      "___ returned without organisms so antibiotics were \n",
      "discontinued. Biopsy results returned on ___ and were positive \n",
      "for toxoplasmosis. The patient was continued on pyrimethamine, \n",
      "clindamycin and leucovorin per ID recommendations. Pt had repeat \n",
      "MRI on ___ which showed a decrease ___ size of the enhancing \n",
      "intracranial lesions, as well as decrease ___ the extent of mass \n",
      "effect, without any new lesions. Mannitol was discontinued, and \n",
      "dexamethasone was reduced to 2 mg IV Q12H to be continued \n",
      "pending improved edema on next MRI. He will be continued on the \n",
      "same regimen of pyrimethamine, clindamycin and leucovorin x 6 \n",
      "weeks (Day ___. His Dexamethasone was changed to 2mg PO \n",
      "at the time of discharge and should be continued at same dose \n",
      "until ID and Neuro outpatient f/u. \n",
      ".\n",
      "# Acute Encephalopathy. Likely related to toxoplasmosis, brain \n",
      "edema, seizure and impending herniation at time of presentation. \n",
      "___ to arrival at ___, the patient was intubated at ___ \n",
      "___, wherein a CT scan showed large left sided brain mass. \n",
      "He was transferred to the ___. A brain MRI showed two left \n",
      "sided brain masses and an additional smaller one on the right, \n",
      "with impending uncal herniation. His pupil dilated acutley while \n",
      "___ the FICU. He was transferred to the SICU on the afternoon of \n",
      "___. At this time, he underwent brain biopsy of these lesions. \n",
      "Reports of seizure-like activity, especially given \n",
      "subtherapeutic phenobarb level as well as ___ setting of \n",
      "presumably new brain mass. Continued phenobarab, started keppra \n",
      "and propofol. Continous EEG with MRI compatible leads placed \n",
      "which showed background slowing and episodes of focal slowing \n",
      "consistent with encephalopathy and subcortical dysfunction. \n",
      "Pathology demonstrated two biopsies consistent with cerebral \n",
      "toxoplasmosis. Mental status began to improve gradually with \n",
      "treatment of elevated ICP and toxoplasma infection. On ___ he \n",
      "underwent MRI scan which showed stable disease. ___ brain MRI \n",
      "showed decreased lesion size and decreased mass effect. By time \n",
      "of discharge, the patient was more alert and responsive: \n",
      "tracking well, responding to verbal commands such as wiggling \n",
      "toes, and squeezing his hand to respond to yes/no questions, \n",
      "though he continues to be non verbal (trach'ed). It is unclear \n",
      "the extent to which Mr ___ recover his pre-admission \n",
      "cognitive baseline; would expect a prolonged and incomplete \n",
      "recovery. \n",
      ".\n",
      "# Hypoxic Respiratory Failure: Pt noted to be hypoxic despite \n",
      "apparent good oxygenation. Methemoglobin level was 9. ID \n",
      "consulted for a substitute for Dapsone, which was thought to be \n",
      "causing his methemoglobinemia. Pt was started on pyrimethamine. \n",
      "During the hospital course, the patient also developed \n",
      "Ventilator-associated pneumonia. He was covered with vancomycin, \n",
      "cefepime, as well as clindamycin. He underwent a trial of \n",
      "extubation on ___, failed and was reintubated the same day. He \n",
      "underwent bronch and BAL which initially showed only commensal \n",
      "respiratory flora, though several days later returned positive \n",
      "for CMV and HSV; pt was treated with ganciclovir. On ___ a \n",
      "tracheostomy tube was placed. Acid fast staining of sputum \n",
      "cultures and PPD were also negative. ___ and ___ sputum \n",
      "cultures grew MRSA which was treated with vancomycin. Repeat BAL \n",
      "on ___ grew staph aureus and vancomycin treatment was \n",
      "continued. Aspergillus galactomman antigen returned positive on \n",
      "___ and repeat was positive from ___. Per ID recommendations, \n",
      "because the patient was clinically stable it was not necessary \n",
      "to begin voriconazole treatment unless he were to deteriorate.  \n",
      "At time of discharge his ABx tehrapy consists of: ganciclovir 25 \n",
      "mg IV every 12 hours for HSV/CMV (last day ___, vanganciclovir \n",
      "for HSV/CMV 900mg po daily from (___), vancomycin for MRSA \n",
      "growth (last day ___.\n",
      ".\n",
      "# HIV/AIDS - Multiple ___ oppurtunistic infections \n",
      "(toxoplasmosis, PCP, LIP). Per ID note at ___, no recent \n",
      "resistant mutations on genotype. Not compliant with ARV regimen. \n",
      "CD4 count was 12 with a viral load of 244 copies/mL. The patient \n",
      "was continued on Truvada and raltegravir per ID recommendations. \n",
      "He was continued on weekly azithromycin for ___ prophylaxis. PCP \n",
      "prophylaxis was later changed to atovaquone, as the ID team felt \n",
      "Dapsone may have contributed to methemaglobinemia. Given BAL \n",
      "finding of CMV, ophtho did a retinal exam which did not show any \n",
      "evidence of toxo or CMV retinitis. Per ID recommendations, \n",
      "raltegravir was discontinued and darunavir/ritonavir were \n",
      "restarted. HIV Genotype was sent ___ however, it was unable \n",
      "to be performed as the pt's viral load was <1000, so the test \n",
      "was cancelled. HIV VL will need to be checked at some point on \n",
      "an outpatient basis. \n",
      ".\n",
      "# Thrush/esophagitis: Pt had white oral secretions and \n",
      "complained of throat pain. He was started on empiric therapy \n",
      "with fluconazole. Last dose of Fluconazole was ___.  \n",
      ".\n",
      "# Transaminitis: New since ___, AST 39, ALT 84, AP 66, bili \n",
      "0.7 when last checked on ___. Hepatitis serologies were \n",
      "negative for acute infection with HBV or HCV. The patient is not \n",
      "immune to HBV. RUQ U/S was within normal limits. His protease \n",
      "inhibitor was initially held as above, and then restarted. \n",
      "Likely related to polypharmacy, sepsis. LFTs had largely \n",
      "normalized at the time of discharge. \n",
      ".\n",
      "# Leukocytosis: On ___, patient had WBC elevation to 12.5, up \n",
      "to 17.2 on ___. Patient remained clinically and hemodynamically \n",
      "stable, with no increase ___ oxygen requirements. Blood, urine \n",
      "and sputum cultures were unchanged from ___ (with normal WBC). \n",
      "CT imaging on ___ showed small amout of free air and pt was \n",
      "evaluated by surgery. They adjusted his PEG tube but did not \n",
      "think this was reason for leukocytosis. He had a large BM on ___ \n",
      "and his WBC count normalized on ___. C diff was sent on ___ and \n",
      "was negative (had also been negative on ___. Leukocytosis \n",
      "thought to be related to constipation, as no other source was \n",
      "found, he remained afebrile and he clinically continued to \n",
      "improve throughout his course on the medical floor. \n",
      ".\n",
      "# History of seizures. Continued on Phenobarbital, added on \n",
      "Keppra. Neuro evaluated ___ and felt pt was not having not \n",
      "seizures; pt was continued with on keppra and phenobarbital. Per \n",
      "neurology recommendations, he underwent phenobarb taper to 15mg \n",
      "on ___ this should be discontinued on ___. He should remain on \n",
      "keppra on an ongoing basis. Further titration of antiepileptics \n",
      "per outpatient Neurology. \n",
      ".\n",
      "# History of chronic diarrhea- C diff was negative on ___ and \n",
      "___, not changed from baseline; likely related to HIV, \n",
      "antibiotics. \n",
      ".\n",
      "# Rash: Pt had a Hypopigmented macular rash on plantar aspect of \n",
      "feet. Skin biopsy  from right arm was non-specific; immunostains \n",
      "for toxo and treponemes were negative.\n",
      ".\n",
      "TRANSITIONAL ISSUES:\n",
      "- For MRSA PNA, patient receiving 2 week course of vancomycin \n",
      "(last day ___. \n",
      "- For Toxoplasmosis, pyrimethamine/leucovorin/clindamycin (last \n",
      "dose ___. \n",
      "- For HSV/CMV PNA, ganciclovir at 425mg IV q12 x3 weeks (last \n",
      "day ___, then valgancyclovir 900mg po qday for another 21 days \n",
      "(___)\n",
      "- Is getting 200ml free water flushs q8h; he should have weekly \n",
      "electrolytes checked and free H2O can be adjusted as needed with \n",
      "extra salt tablets given if necessary\n",
      "- Patient is not immune to HBV and should be vaccinated\n",
      "- Should have MRI with and without contrast, roughly 2 weeks \n",
      "from discharge (scheduled for ___\n",
      "- Continue dexamethasone 2mg po q12. Discontinuation of this at \n",
      "the discretion of outpatient ID and Neurology attendings. \n",
      "- Continue to monitor for abnormal movements. If they occur with \n",
      "increased frequency or intensity, would recommend 24-hour EEG \n",
      "monitoring with video to further evaluate.  \n",
      "- ___ ad lib, no restrictions with focus on range of motion and \n",
      "decreasing contractions. ___ consider splinting UE during sleep. \n",
      " \n",
      "- To resend HIV genotyping, patient will need concurrent viral \n",
      "load ordered. Need >1000 copies to perform the test\n",
      "- The patient had two positive galactomannan antigen (serum) \n",
      "with antigen ___ BAL negative. Per ID, not starting voriconazole \n",
      "but would re-evaluate should the patient decompensate.\n",
      "\n",
      "-The following studies were pending at time of discharge:\n",
      "___ 15:10  BLOOD CULTURE Blood Culture, Routine\n",
      "___ 15:10  BLOOD CULTURE Blood Culture, Routine\n",
      "___ 14:45  SPUTUM RESPIRATORY CULTURE; LEGIONELLA CULTURE; \n",
      "FUNGAL CULTURE\n",
      "___ 08:39  BLOOD CULTURE Blood Culture, Routine\n",
      "___ 02:50  BLOOD CULTURE Blood Culture, Routine\n",
      "___ 13:07  BRONCHOALVEOLAR LAVAGE FUNGAL CULTURE; ACID FAST \n",
      "CULTURE; VIRAL CULTURE: R/O CYTOMEGALOVIRUS\n",
      "___ 17:41  BRONCHOALVEOLAR LAVAGE NOCARDIA CULTURE; ACID \n",
      "FAST CULTURE\n",
      "___ 04:52  SPUTUM ACID FAST CULTURE\n",
      "___ 17:05  SPUTUM ACID FAST CULTURE\n",
      "___ 10:36  SPUTUM ACID FAST CULTURE\n",
      "___ 22:16  BIOPSY FUNGAL CULTURE; ACID FAST CULTURE; VIRAL \n",
      "CULTURE\n",
      "___ 22:16  BIOPSY FUNGAL CULTURE; ACID FAST CULTURE; VIRAL \n",
      "CULTURE\n",
      "___ 22:16  BIOPSY FUNGAL CULTURE; ACID FAST CULTURE; VIRAL \n",
      "CULTURE\n",
      "___ 12:08  BLOOD CULTURE ( MYCO/F LYTIC BOTTLE) \n",
      "BLOOD/FUNGAL CULTURE; BLOOD/AFB CULTURE\n",
      "\n",
      "- DISCHARGED TO: ___\n",
      "- FULL CODE\n",
      "\n",
      " \n",
      "Medications on Admission:\n",
      "The Preadmission Medication list is accurate and complete.\n",
      "1. albuterol sulfate *NF* 2.5 mg/0.5 mL Inhalation Q6 hours  as \n",
      "needed for shortness of breath or wheezing \n",
      "2. Ipratropium Bromide Neb 1 NEB IH Q6H as needed for shortness \n",
      "of breath \n",
      "3. Dapsone 50 mg PO DAILY \n",
      "4. PredniSONE 30 mg PO DAILY \n",
      "5. Potassium Chloride 40 mEq PO DAILY \n",
      "6. OxycoDONE (Immediate Release)  5 mg PO QHS:PRN pain \n",
      "7. Lorazepam 1 mg PO HS:PRN insomnia \n",
      "8. PHENObarbital 30 mg PO DAILY \n",
      "9. Raltegravir 400 mg PO BID \n",
      "10. RiTONAvir 100 mg PO BID \n",
      "11. Darunavir 600 mg PO BID \n",
      "12. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n",
      "\n",
      " \n",
      "Discharge Medications:\n",
      "1. Darunavir 800 mg PO DAILY \n",
      "2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY \n",
      "3. Ipratropium Bromide Neb 1 NEB IH Q6H as needed for shortness \n",
      "of breath \n",
      "4. OxycoDONE (Immediate Release)  2.5 mg PO Q8H:PRN Pain \n",
      "5. PHENObarbital 15 mg PO DAILY \n",
      "last day ___ \n",
      "6. RiTONAvir 100 mg PO DAILY \n",
      "7. Leucovorin Calcium 25 mg PO DAILY \n",
      "(day 1 ___, last ___ \n",
      "8. LeVETiracetam 1250 mg PO Q12H \n",
      "9. Pyrimethamine 75 mg PO DAILY \n",
      "(day 1= ___, last ___ \n",
      "10. Dexamethasone 2 mg IV Q12H \n",
      "11. Clindamycin 600 mg IV Q6H \n",
      "(day 1 ___, last ___  \n",
      "12. Vancomycin 1250 mg IV Q 8H \n",
      "Last day: ___ or as per directed by ID. \n",
      "13. Azithromycin 1200 mg PO 1X/WEEK (___) \n",
      "14. Atovaquone Suspension 1500 mg PO DAILY \n",
      "15. Senna 1 TAB PO BID:PRN constipation \n",
      "Please hold for loose stools. \n",
      "16. Docusate Sodium 100 mg NG BID:PRN constipation \n",
      "17. Albuterol 0.083% Neb Soln 1 NEB IH Q6H \n",
      "18. Dextrose 50% 12.5 gm IV PRN hypoglycemia protocol \n",
      "19. Glucagon 1 mg IM Q15MIN:PRN hypoglycemia protocol \n",
      "20. Glucose Gel 15 g PO PRN hypoglycemia protocol \n",
      "21. Heparin 5000 UNIT SC TID \n",
      "22. Insulin SC \n",
      "      Sliding Scale\n",
      "\n",
      "Fingerstick QACHS\n",
      "Insulin SC Sliding Scale using HUM Insulin\n",
      "23. ValGANCIclovir 900 mg PO DAILY \n",
      "Start day ___.  End day ___. Outpatient Lab Work\n",
      "Please draw CBC two times per week. Please fax results to ___, Attn: ___ MD\n",
      "___ Code: ___\n",
      "25. Outpatient Lab Work\n",
      "Please draw Renal function panel one time per week. Please fax \n",
      "results to ___, Attn: Dr. ___\n",
      "ICD 9-code: ___\n",
      "26. Ganciclovir 425 mg IV Q12H CMV/HSV coinfection \n",
      "last day ___. Sodium Chloride 1 gm PO DAILY \n",
      "\n",
      " \n",
      "Discharge Disposition:\n",
      "Extended Care\n",
      " \n",
      "Facility:\n",
      "___\n",
      " \n",
      "Discharge Diagnosis:\n",
      "Primary diagnosis:\n",
      "- Toxoplasmosis\n",
      "- Ventilator-associated pneumonia \n",
      "- MRSA/HSV/CMV Pneumonia\n",
      "- HIV/AIDS\n",
      "\n",
      " \n",
      "Discharge Condition:\n",
      "Mental Status: Confused - sometimes.\n",
      "Level of Consciousness: Lethargic but arousable.\n",
      "Activity Status: Ambulatory - requires assistance or aid (walker \n",
      "or cane).\n",
      "\n",
      " \n",
      "Discharge Instructions:\n",
      "Dear Mr. ___,\n",
      "\n",
      "It was a pleasure caring for you during your hospitalization at \n",
      "___. You were admitted on ___ from another hospital after \n",
      "you had difficulty breathing and some changes ___ your mentation. \n",
      "You were very, very sick. You required a tube to help you \n",
      "breathe and were found to have masses ___ your brain. There was \n",
      "swelling from the masses and this was pushing on your brain so \n",
      "you were treated with medications to help decrease the pressure \n",
      "from this swelling. A brain biopsy showed that the masses were \n",
      "from an infection, called toxoplasmosis, and you were started on \n",
      "medicines that will help treat this disease. You had repeat \n",
      "imaging (an MRI) that showed that the masses had decreased \n",
      "slightly ___ size towards the end of your hospitalization. You \n",
      "will have another MRI ___ a couple of weeks so that your brain \n",
      "infections and swelling can be monitored. You also had multiple \n",
      "infections ___ your lungs. When you had the breathing tube, you \n",
      "were found to have a pneumonia that was treated with \n",
      "antibiotics. To identify other organisms that were infecting \n",
      "your lungs, you had a procedure called a bronchoscopy, where a \n",
      "tube was placed down your windpipe. You were found to have \n",
      "multiple infectious organisms ___ your lungs, and you were \n",
      "continued on antibiotics and antiviral medications to treat \n",
      "these infections.  These medications will also need to be \n",
      "continued.\n",
      "\n",
      "After your breathing tube was removed, you were having trouble \n",
      "breathing on your own. You had a surgery to make a hole ___ your \n",
      "windpipe (called a tracheostomy) to help you breathe. To help \n",
      "you get the nutrition you require, you had another surgery to \n",
      "put ___ a feeding tube. \n",
      "\n",
      "You also were kept on anti-retroviral medications for your \n",
      "HIV/AIDS. Your T cell count was very low (CD4 count of 12) and \n",
      "you were followed by the Infectious Disease doctors. ___ to \n",
      "admission, you also had been taking medications to prevent \n",
      "certain infections that are more frequent ___ patients with AIDS. \n",
      "Please note that changes were made to this regimen while you \n",
      "were ___ the hospital and you have been discharged on different \n",
      "medications. \n",
      "\n",
      "You have a history of seizures and had been taking a medication \n",
      "called phenobarbital. While you were ___ the hospital, you were \n",
      "seen by the Neurology Service and you were slowly weaned off of \n",
      "the phenobarbital and started on a different medication \n",
      "(Keppra). \n",
      "\n",
      "You will be followed by both the Infectious Disease clinic (to \n",
      "monitor the treatment of your multiple lung infections) and the \n",
      "Neurology clinic (see below for appointment information). You \n",
      "have been started on many new medications to help treat the \n",
      "infections ___ your brain and ___ your lungs and to treat the \n",
      "swelling ___ your brain and prevent seizures. Please make sure to \n",
      "take these medications appropriately as this is important for \n",
      "your continued treatment and recovery.\n",
      "\n",
      "If you develop any fevers, chills, difficulty breathing, \n",
      "numbness, tingling, weakness, chest pain, palpitations, vision \n",
      "changes, or any other concerning symptoms, please call your \n",
      "doctor right away.\n",
      "\n",
      "We wish you the best of luck!\n",
      " \n",
      "Followup Instructions:\n",
      "___\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(tokens_rad[int(np.argmax(note_token_lens_rad))]['text'])\n",
    "print(tokens_dis[int(np.argmax(note_token_lens_dis))]['text'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Let's find note count per icustay"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "note_counts_rad = rad_c_df.groupby('ICUSTAY_ID')['NOTE_ID'].count()\n",
    "note_counts_dis = dis_c_df.groupby('ICUSTAY_ID')['NOTE_ID'].count()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "MEAN: 2.8106152880817925\n",
      "MEDIAN: 2.0,\n",
      "MAX: 44\n",
      "MIN: 1\n",
      "MEAN: 1.0690287558685445\n",
      "MEDIAN: 1.0,\n",
      "MAX: 2\n",
      "MIN: 1\n"
     ]
    }
   ],
   "source": [
    "summary_stats(note_counts_rad)\n",
    "summary_stats(note_counts_dis)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "While there are 2 or 3 radiology reports per stay, there is almost always only 1 discharge report per stay.\n",
    "Thus, discharge notes can only be of limited use in real-time survival analysisby relying only on discharge reports from previous stays.\n",
    "Radiology reports, on the other hand, provide recent information on patient condition. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Further analysis\n",
    "Given that there is only one discharge per icustay, how many patients have multiple stays? In other words, how many patients would benefit from the inclusion of discharge notes?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "trainpath = '/home/ugrads/a/aa_ron_su/BoXHED_Fuse/JSS_SUBMISSION_NEW/data/till_end_mimic_iv_extra_features_train.csv'\n",
    "mimic_iv_train = pd.read_csv(trainpath)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "mimic_iv_train.rename(columns={'Icustay':'ICUSTAY_ID', 'subject':'SUBJECT_ID'}, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "rad_c_df_w_subj = rad_c_df.merge(mimic_iv_train[['ICUSTAY_ID', 'SUBJECT_ID']], on='ICUSTAY_ID', how='inner')\n",
    "dis_c_df_w_subj = dis_c_df.merge(mimic_iv_train[['ICUSTAY_ID', 'SUBJECT_ID']], on='ICUSTAY_ID', how='inner')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "radiology note counts by subject\n",
      " SUBJECT_ID\n",
      "10000032.0    1\n",
      "10000980.0    1\n",
      "10001217.0    3\n",
      "10001725.0    1\n",
      "10002013.0    2\n",
      "             ..\n",
      "19999287.0    5\n",
      "19999297.0    8\n",
      "19999442.0    4\n",
      "19999625.0    2\n",
      "19999987.0    2\n",
      "Name: NOTE_ID, Length: 22725, dtype: int64\n",
      "radiology note counts by subject\n",
      " SUBJECT_ID\n",
      "10000032.0    1\n",
      "10000980.0    1\n",
      "10001217.0    1\n",
      "10002013.0    1\n",
      "10002155.0    1\n",
      "             ..\n",
      "19998843.0    1\n",
      "19999287.0    1\n",
      "19999297.0    1\n",
      "19999442.0    1\n",
      "19999625.0    1\n",
      "Name: NOTE_ID, Length: 11042, dtype: int64\n"
     ]
    }
   ],
   "source": [
    "subject_note_counts_rad = rad_c_df_w_subj.groupby('SUBJECT_ID')['NOTE_ID'].nunique()\n",
    "subject_note_counts_dis = dis_c_df_w_subj.groupby('SUBJECT_ID')['NOTE_ID'].nunique()\n",
    "\n",
    "print('radiology note counts by subject\\n', subject_note_counts_rad)\n",
    "print('radiology note counts by subject\\n', subject_note_counts_dis)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "MEAN: 3.350847084708471\n",
      "MEDIAN: 3.0,\n",
      "MAX: 44\n",
      "MIN: 1\n",
      "MEAN: 1.3197790255388517\n",
      "MEDIAN: 1.0,\n",
      "MAX: 6\n",
      "MIN: 1\n"
     ]
    }
   ],
   "source": [
    "summary_stats(subject_note_counts_rad)\n",
    "summary_stats(subject_note_counts_dis)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Even when grouping by subject, most patients only have 1 discharge summary. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "clinical1",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
